Intrathyroidal feedforward and feedback network regulating thyroid hormone synthesis and secretion
Open accessAbstract
Thyroid hormones (THs), including T4 and T3, are produced and released by the thyroid gland under the stimulation of thyroid-stimulating hormone (TSH). The homeostasis of THs is regulated via the coordination of the hypothalamic-pituitary-thyroid axis, plasma binding proteins, and local metabolism in tissues. TH synthesis and secretion in the thyrocytes-containing thyroid follicles are exquisitely regulated by an elaborate molecular network comprising enzymes, transporters, signal transduction machineries, and transcription factors. In this article, we synthesized the relevant literature, organized and dissected the complex intrathyroidal regulatory network into structures amenable to functional interpretation and systems-level modeling. Multiple intertwined feedforward and feedback motifs were identified and described, centering around the transcriptional and posttranslational regulations involved in TH synthesis and secretion, including those underpinning the Wolff-Chaikoff and Plummer effects and thyroglobulin-mediated feedback regulation. A more thorough characterization of the intrathyroidal network from a systems biology perspective, including its topology, constituent network motifs, and nonlinear quantitative properties, can help us to better understand and predict the thyroidal dynamics in response to physiological signals, therapeutic interventions, and environmental disruptions.
AI snapshot
Written from the paper’s full text.
TL;DR
This review synthesizes the literature on the intrathyroidal molecular network controlling thyroid hormone (TH) synthesis and secretion, reorganizing it into interconnected feedforward and feedback motifs amenable to systems-level modeling. It argues that these motifs—centered on TSH signal transduction, thyroid transcription factors (TTFs), and thyroglobulin (TG)- and iodide-mediated regulation—explain phenomena such as the biphasic TSH response, the Wolff-Chaikoff and Plummer effects, and follicular heterogeneity.
Key findings
- The intrathyroidal network is dominated by coherent and incoherent feedforward motifs: TSH activates Gαs/cAMP/PKA and Gαq/11/PKC pathways that diverge and converge on TTFs (TTF1, TTF2, PAX8, HHEX) and functional genes (NIS, TG, TPO, PDS, DUOX(A)1/2, DIO1/2, TSHR), with the Gαs/Gαi/o incoherent motif proposed to underlie the bell-shaped cAMP and gene-expression response to TSH (peak ~10 mU/mL).
- High iodine produces two mechanistically distinct effects: the Wolff-Chaikoff effect (inhibition of iodide organification, requiring intracellular iodide ≥1 mM, transient for ~26–50 h in rats) and the Plummer effect (inhibition of TH secretion via reduced TG proteolysis and MCT8 downregulation); escape involves NIS downregulation (NIS protein half-life shortened from 4 days to 24 h), PDS upregulation, and decreased DEHAL/DIO1.
- TG in the follicular lumen acts as a concentration-dependent negative feedback suppressor of TG, NIS, TPO, DUOX2, DUOXA2, TTF1, TTF2, PAX8, and TSHR, while upregulating PDS, cathepsin H, and MCT8; this feedback is proposed to act as an oscillator driving the thyroid follicular cycle and follicle heterogeneity.
- Quantitative anchors cited: ~99.97% of T4 and 99.70% of T3 are protein-bound (TBG ~75%, TTR ~15%, albumin ~10% of plasma THs); human TG is a 660 kDa homodimer with 67 tyrosines (~30 iodinable; 4 acceptors, 5 donors) carrying on average 2.28 T4 and 0.29 T3; luminal TG reaches ~600 mg/ml and >95% of colloid protein; the human thyroid contains ~10–15 mg iodine; free TH is held within a 2–3 fold range.
Methods
Narrative literature review and synthesis; no primary data or new experiments. The authors organize published molecular findings (largely from rat thyroid cell lines such as FRTL-5 and PCCl3, primary human thyrocytes, and rodent in vivo studies) into network-motif structures (feedforward, feedback, autoregulation) and discuss them qualitatively. They also review prior mathematical models of the HPT axis and intrafollicular iodine turnover (e.g., Degon et al., Berberich et al., Cohen et al.) as a basis for future dynamical modeling.
Limitations
The authors explicitly state that many reviewed regulations derive from in vitro and in vivo studies across various species, particularly rat thyroid cell lines, so caution is needed when generalizing; they also note the review is not intended as a comprehensive enumeration of molecular details. The text makes evident additional caveats: the Plummer effect is more variable and less persistent in rodents than humans (with conflicting rat studies), the mechanisms transducing TG signals via ASGPR/flotillin are unclear, the mechanism of PLC/PKC suppression of cAMP/PKA "remains to be identified," and the functional significance of the biphasic TSH response is "not clear."
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
65 of 149 cited sources checked · 26 supported · 0 flagged · accuracy not yet measured
- Premisecitation
T3 upregulates expression of pyroglutamyl peptidase II in tanycytes of the median eminence, which degrades locally released TRH.
“in the tanycytes located in the median eminence, T3 can upregulate the expression of pyroglutamyl peptidase II, which is a highly specific TRH peptidase that degrades the locally released TRH before it reaches the portal vein system (19).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [19] Marsili, 2011, Thyroxine-induced expression of pyroglutamyl peptidase II and inhibition of TSH release precedes suppression of TRH mRNA and requires type 2 deiodinase, J Endocrinol source
The Results report a significant rise in PPII mRNA in median-eminence tanycytes after T3 treatment, and the Introduction identifies PPII as a highly specific TRH peptidase. The Discussion describes degradation of TRH at tanycyte processes in the median eminence as a potential mechanism, not a demonstrated event before TRH reaches the portal vein system. Our copy provides no direct evidence for that precise route or timing. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
TH homeostasis is maintained globally and locally through multiple mechanisms that coordinately regulate the production, secretion, distribution, and metabolism of THs.
“TH homeostasis is maintained both globally and locally through multiple mechanisms that coordinately regulate the production, secretion, distribution, and metabolism of THs.”
Quote in the paperSubstantial claim1 of 4 sources checked- cites [6] Silva, 1977, Pituitary nuclear 3,5,3’-triiodothyronine and thyrotropin secretion: an explanation for the effect of thyroxine, Science source
- cites [7] Fonseca, 2013, Coordination of hypothalamic and pituitary T3 production regulates TSH expression, J Clin Invest source
The Introduction (p. 1) describes feedback that regulates thyroid hormone synthesis and secretion, while the paper’s opening summary (p. 1) describes coordinated local T4-to-T3 conversion that maintains normal plasma T3. These passages support global and local regulation of production and metabolism, but our copy does not establish coordinated regulation of thyroid hormone distribution. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [8] van der Spek, 2017, The classic pathways of thyroid hormone metabolism, Mol Cell Endocrinol source
- cites [9] Luongo, 2019, Deiodinases and their intricate role in thyroid hormone homeostasis, Nat Rev Endocrinol source
- Premisecitation
Proteolysis of TG releases 6 or 7 times more MIT and DIT than T3 and T4.
“Proteolysis of TG releases 6 or 7 times more MIT and DIT than T3 and T4 (97).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [97] Rokita, 2010, Efficient use and recycling of the micronutrient iodide in mammals, Biochimie source
- Premisecitation
The classical feedback regulation of the HPT axis is the primary mechanism for chronically maintaining circulating free TH levels within the physiological range.
“The classical feedback regulation of the HPT axis is the primary mechanism for chronically maintaining the circulating free TH levels within the physiological range (15).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [15] Duntas, 2016, NEW INSIGHTS INTO THE HYPOTHALAMIC-PITUITARY-THYROID AXIS, Acta Endocrinol (Buchar) source
The Introduction (pp. 126–127) describes thyroid-hormone feedback on TRH and TSH and calls TRH’s role in thyroid homeostasis well established. It does not specifically establish that classical feedback is the primary mechanism for chronically keeping circulating free thyroid-hormone levels within the physiological range. (LLM, conf=0.83)
Experimental — accuracy not yet measured
- Premisecitation
T3 induces DIO1 transcription by binding to two TREs in the gene promoter in tissues including the liver.
“T3 can induce DIO1 transcription by binding to two TREs in the gene promoter in tissues including the liver (34–36).”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [34] Toyoda, 1995, A novel retinoid X receptor-independent thyroid hormone response element is present in the human type 1 deiodinase gene, Mol Cell Biol source
The paper reports two TREs in the human DIO1 promoter that contribute to T3 induction, and increased DIO1 mRNA after T3 exposure in HepG2 liver-derived cells. It says T3 binds the thyroid hormone receptor, which binds the TREs—not that T3 binds the TREs directly. The evidence for liver is from a liver-derived cell line, not liver tissue itself. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [35] Zhang, 1998, Further characterization of thyroid hormone response elements in the human type 1 iodothyronine deiodinase gene, Endocrinology source
- cites [36] Zavacki, 2005, Type 1 iodothyronine deiodinase is a sensitive marker of peripheral thyroid status in the mouse, Endocrinology source
- Premisecitation
I- is transported into the follicular lumen by apical transporters including pendrin (PDS), anoctamin-1 (ANO1), and SLC26A7.
“it is taken up and transported into the follicular lumen by transporters located on the apical plasma membrane, including pendrin (PDS), anoctamin-1 (ANO1), and SLC26A7 (53, 54).”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [53] Gillam, 2004, Functional characterization of pendrin in a polarized cell system. evidence for pendrin-mediated apical iodide efflux, J Biol Chem source
The Discussion (page not provided) says the study provides evidence that pendrin mediates iodide efflux at the apical membrane. The Results (page not provided) also report iodide transport into the apical chamber in cells expressing pendrin. Our copy does not identify ANO1 or SLC26A7 as apical iodide transporters, so it supports only the pendrin part of the cited sentence. (LLM, conf=0.90)
Experimental — accuracy not yet measured - cites [54] Twyffels, 2014, Anoctamin-1/TMEM16A is the major apical iodide channel of the thyrocyte, Am J Physiol Cell Physiol source
- Premisecitation
ASGPR can bind more recently synthesized, poorly iodinated and sialylated TG and route them away from the lysosomal pathway such that they serve as negative feedback signals to repress thyroid-specific TFs (TTFs).
“ASGPR can also bind more recently synthesized, poorly iodinated and sialylated TG and route them away from the lysosomal pathway such that they serve as negative feedback signals to repress thyroid-specific TFs (TTFs) (68, 92).”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [68] Ulianich, 1999, Follicular thyroglobulin (TG) suppression of thyroid-restricted genes involves the apical membrane asialoglycoprotein receptor and TG phosphorylation, J Biol Chem source
The passage labeled Abstract (page unavailable) hypothesizes that apical ASGPR binds recently synthesized, poorly iodinated and poorly sialylated TG, sequestering it from fluid pinocytosis. The same section supports ASGPR-mediated suppression of thyroid-restricted transcription factors, but does not establish that ASGPR routes TG away from lysosomes; it also describes the selective binding as a hypothesis, not a demonstrated pathway. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [92] Consiglio, 1979, Thyroglobulin interactions with thyroid plasma membranes. the existence of specific receptors and their potential role, J Biol Chem source
- Premisecitation
T3 represses transcription of the TRH gene via TH receptor β2 in TRH neurons of the hypothalamic paraventricular nucleus.
“in the TRH neurons located in the hypothalamic paraventricular nucleus, T3 represses the transcription of the TRH gene via TH receptor β2 (TRβ2) (17).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [17] Abel, 2001, Critical role for thyroid hormone receptor beta2 in the regulation of paraventricular thyrotropin-releasing hormone neurons, J Clin Invest source
- Premisecitation
Cathepsins B and L in the lumen are involved in proteolytic solubilization of TG from covalently cross-linked TG globules.
“Cathepsins B and L in the lumen are involved in proteolytic solubilization of TG from covalently cross-linked TG globules (89).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [89] Friedrichs, 2003, “Thyroid functions of mouse cathepsins b, K and l, J Clin Invest source
- Premisecitation
CAV1 is required for the correct positioning of TPO and DUOX on the apical membrane, bringing them together in the thyroxisome.
“CAV1 is required for the correct positioning of TPO and DUOX on the apical membrane (61, 62), bringing the two together in the thyroxisome (63).”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [61] Senou, 2009, Role of caveolin-1 in thyroid phenotype, cell homeostasis, and hormone synthesis: in vivo study of caveolin-1 knockout mice, Am J Physiol Endocrinol Metab source
- cites [62] Senou, 2010, A coherent organization of differentiation proteins is required to maintain an appropriate thyroid function in the pendred thyroid, J Clin Endocrinol Metab source
- cites [63] Godlewska, 2019, Thyroid peroxidase as a dual active site enzyme: Focus on biosynthesis, hormonogenesis and thyroid disorders of autoimmunity and cancer, Biochimie source
- Premisecitation
T3 represses transcription of the TSHβ subunit in pituitary thyrotrophs by inhibiting via TRβ2 the autoregulation of GATA2.
“In the pituitary thyrotrophs, T3 represses the transcription of the TSHβ subunit by inhibiting via TRβ2 the autoregulation of GATA2, a key transcription factor that mediates the TRH-stimulated TSH production (18).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [18] Hirahara, 2020, Liganded T3 receptor β2 inhibits the positive feedback autoregulation of the gene for GATA2, a transcription factor critical for thyrotropin production, PLoS One source
The Discussion (Fig. 7) says liganded TRβ2 inhibits TSHβ transcription and suggests that it also inhibits GATA2 positive-feedback autoregulation. The Abstract reports the autoregulation experiments in kidney-derived CV1 cells and the T3 response in gonadotroph-derived LβT2 cells. The proposed causal route is therefore supported, but the claim presents it as established in pituitary thyrotrophs rather than as a mechanism suggested by those experiments. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Premisecitation
High iodine inhibits TH secretion, lowering serum T4 and T3 in humans for days or weeks as long as serum iodide remains high.
“In humans, serum T4 and T3 quickly decreased after high iodine intake and the decrease could persist for days or even weeks as long as the serum iodide remained high (209–211).”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [209] Mercer, 1960, Slowing of thyroid secretion by iodide: in euthyroid people, Lancet source
- cites [210] Vagenakis, 1973, Control of thyroid hormone secretion in normal subjects receiving iodides, J Clin Invest source
- cites [211] Namba, 1993, Evidence of thyroid volume increase in normal subjects receiving excess iodide, J Clin Endocrinol Metab source
- Interpretationcitation
The biphasic responses to TSH may originate from biphasic cAMP activation by TSH.
“The biphasic responses may originate from the biphasic cAMP activation by TSH as demonstrated ex vivo in human thyroid tissues (201).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [201] Laurent, 1991, Unlike thyrotropin, thyroid-stimulating antibodies do not activate phospholipase c in human thyroid slices, J Clin Invest source
- Premisecitation
TSH-stimulated PKA can phosphorylate PDS to promote its membrane translocation, leading to increased iodide efflux into the follicular lumen.
“TSH-stimulated PKA can phosphorylate PDS to promote its membrane translocation, leading to increased iodide efflux into the follicular lumen (173, 174).”
Quote in the paperNot a substantial claim1 of 2 sources checked - Premisecitation
The Gβγ-activated PI3K/AKT signaling pathway can cause PAX8 exclusion from the nucleus and thus inhibit PAX8-mediated NIS transcription in PCCl3 cells.
“The Gβγ-activated PI3K/AKT signaling pathway can cause PAX8 exclusion from the nucleus and thus inhibit PAX8-mediated NIS transcription in PCCl3 cells (112).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [112] Zaballos, 2008, Gbetagamma dimers released in response to thyrotropin activate phosphoinositide 3-kinase and regulate gene expression in thyroid cells, Mol Endocrinol source
- Premisecitation
In primary human thyrocytes, knockdown of TTF1, TTF2, PAX8 but not HHEX markedly inhibits TSH-stimulated NIS mRNA expression.
“In primary human thyrocytes, knockdown of TTF1, TTF2, PAX8 but not HHEX genes markedly inhibited TSH-stimulated NIS mRNA expression (163).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [163] Jang, 2020, Thyrotropin regulation of differentiated gene transcription in adult human thyrocytes in primary culture, Mol Cell Endocrinol source
- Premisecitation
The DNA binding sites of TTF1 and PAX8 often colocalize in the promoters of target genes.
“the DNA binding sites of TTF1 and PAX8 often colocalize in the promoters of target genes (143).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [143] López-Márquez, 2021, Unraveling the complex interplay between transcription factors and signaling molecules in thyroid differentiation and function, from embryos to adults, Front Endocrinol (Lausanne) source
The Regulation of Thyroid Differentiation Genes section (page unavailable) says thyroid transcription factors bind consensus sites within target promoters, and the References list cites a study of TTF1 and PAX8 synergistically activating the thyroglobulin promoter. Neither passage says their DNA-binding sites colocalize or that this occurs often across target-gene promoters. (LLM, conf=0.78)
Experimental — accuracy not yet measured
- Premisecitation
Upregulation of DIO1 and DIO2 by TSH is important in establishing the intrathyroidal TSH-T3 shunt pathway to preferentially stimulate T3 production.
“The upregulation of DIO1 and DIO2 by TSH is important in establishing the intrathyroidal TSH-T3 shunt pathway (180) to preferentially stimulate T3 production (181).”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [180] Berberich, 2018, Mathematical modeling of the pituitary-thyroid feedback loop: Role of a TSH-T(3)-Shunt and sensitivity analysis, Front Endocrinol (Lausanne) source
The Introduction and Presentation of the Extended Model describe a TSH-stimulated intrathyroidal TSH–T3 pathway that includes conversion by type 1 and type 2 deiodinases. They do not establish that TSH upregulates both enzymes to create the pathway. The Dynamic Simulation also finds that type 2 deiodinase contributes negligibly to thyroidal T3 production in the modeled parameter set, so the claimed importance of both enzymes is overstated. (LLM, conf=0.87)
Experimental — accuracy not yet measured - cites [181] Citterio, 2017, De novo triiodothyronine formation from thyrocytes activated by thyroid-stimulating hormone, J Biol Chem source
- Premisecitation
In primary human thyrocytes, TSH induces a bell-shaped dose-response of HHEX, TG, NIS, TPO, DIO2, and TSHR mRNA expression and secreted TG protein, with peak response at about 10 mU/mL.
“In primary human thyrocytes, TSH induced bell-shaped dose-response of HHEX, TG, NIS, TPO, DIO2, and TSHR mRNA expression and secreted TG protein (163, 198). The TSH concentration associated with the peak response is about 10 mU/mL.”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [163] Jang, 2020, Thyrotropin regulation of differentiated gene transcription in adult human thyrocytes in primary culture, Mol Cell Endocrinol source
The Results and Discussion report inverted U-shaped TSH responses for HHEX, TG, NIS, TPO, DIO2, and TSHR mRNAs in primary human thyrocytes (page not provided). The Results mention increased TG protein in previous reports, but do not establish a bell-shaped response for secreted TG protein. The Methods use 10 mU/mL TSH for a TPO protein experiment; they do not identify it as the peak dose for the claimed responses. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [198] Jang, 2020, Thyrotropin, but not thyroid-stimulating antibodies, induces biphasic regulation of gene expression in human thyrocytes, Thyroid source
- Premisecitation
The TSH-stimulated Gβγ/PI3K/AKT pathway can induce nuclear exclusion of PAX8 and repress PAX8 binding to NIS enhancers, inhibiting NIS transcription.
“Conversely, the TSH-stimulated Gβγ/PI3K/AKT pathway can somehow induce nuclear exclusion of PAX8 and repress PAX8 binding to the NIS enhancers, thus inhibiting NIS transcription (112).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [112] Zaballos, 2008, Gbetagamma dimers released in response to thyrotropin activate phosphoinositide 3-kinase and regulate gene expression in thyroid cells, Mol Endocrinol source
- Premisecitation
In FRTL-5 cells, TSH-stimulated upregulation of TTF2 mRNA levels appears to be mediated by the cAMP/PKA/CREB pathway.
“in FRTL-5 cells it was found that TSH-stimulated upregulation of TTF2 mRNA levels appears to be mediated by the cAMP/PKA/CREB pathway (154).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [154] Ortiz, 1997, Transcriptional control of the forkhead thyroid transcription factor TTF-2 by thyrotropin, insulin, and insulin-like growth factor I, J Biol Chem source
The Results report that TSH increases TTF-2 mRNA in FRTL-5 cells and that forskolin produces a similar effect; the Discussion says this suggests TSH acts through the cAMP pathway (page numbers unavailable in our copy). The paper does not establish the additional PKA/CREB steps and says further work is needed to determine how TSH regulates TTF-2. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
TTF2 interferes with the binding of TTF1 to the TG promoter, inhibiting its transcriptional activation.
“TTF2 could interfere with the binding of TTF1 to the TG promoter, inhibiting its transcriptional activation (167).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [167] Zannini, 1997, TTF-2, a new forkhead protein, shows a temporal expression in the developing thyroid which is consistent with a role in controlling the onset of differentiation, EMBO J source
The discussion reports that TTF-2 interferes with TTF-1-mediated transcriptional activation of the Tg promoter, supporting the inhibition part of the claim. It does not establish that TTF-2 interferes with TTF-1 binding to that promoter; the same passage says repression persists when TTF-2 binding sites are mutated. The indexed copy gives no page number for this passage. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
TSH can stimulate PAX8 mRNA and protein expression, likely via the CREB binding sites in the PAX8 gene promoter, as demonstrated in PCCl3 and FRTL-5 cells.
“TSH can stimulate PAX8 mRNA and protein expression, likely via the CREB binding sites in the PAX8 gene promoter, as demonstrated in PCCl3 and FRTL-5 cells (144, 153).”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [144] Sastre-Perona, 2014, Wnt-independent role of β-catenin in thyroid cell proliferation and differentiation, Mol Endocrinol source
The Results report TSH-responsive Pax8 expression in PCCl3 cells, and the Discussion says CREB binding sites in the Pax8 promoter help explain TSH/cAMP regulation. However, the reported Pax8 protein increase was observed with an active β-catenin mutant, not explicitly attributed to TSH; the FRTL5 experiments reproduced β-catenin responses, not the claimed Pax8 mRNA and protein response. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [153] Fabbro, 1998, Pax-8 protein levels regulate thyroglobulin gene expression, J Mol Endocrinol source
The Results (Fig. 1; page not specified in our copy) show that TSH increases Pax-8 protein levels in FRTL-5 cells through a cAMP-dependent mechanism. The paper does not demonstrate TSH-induced Pax-8 mRNA expression in these cells, report experiments in PCCl3 cells, or identify CREB binding sites in the PAX8 promoter as the mechanism. (LLM, conf=0.89)
Experimental — accuracy not yet measured
- Premisecitation
TSHR-mediated upregulation of DIO2 contributes significantly to the relative increase in intrathyroidal T4-to-T3 conversion and thus T3 production and higher circulating T3/T4 ratio in patients with Graves' disease and toxic adenomas.
“TSHR-mediated upregulation of DIO2 contributes significantly to the relative increase in intrathyroidal T4-to-T3 conversion and thus T3 production and higher circulating T3/T4 ratio in patients with Graves’ disease and toxic adenomas (182, 183).”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [182] Salvatore, 1996, Type 2 iodothyronine deiodinase is highly expressed in human thyroid, J Clin Invest source
The Abstract reports greater D2-mediated T4-to-T3 conversion in stimulated thyroids and concludes that it may contribute significantly to increased thyroidal T3 production in Graves’ disease and toxic adenomas. The Discussion proposes TSH-related signaling as an explanation for high D2 expression but says other factors remain unidentified. The paper does not establish TSHR-mediated upregulation as the cause or directly show that D2 raises the circulating T3/T4 ratio; section labels are available, but passage page numbers are not. (LLM, conf=0.87)
Experimental — accuracy not yet measured - cites [183] Murakami, 2001, Expression and regulation of type II iodothyronine deiodinase in human thyroid gland, Endocrinology source
- Premisecitation
TG molecules taken up via receptor-mediated mechanisms do not seem to be a significant source of T3 and T4 production.
“TG molecules taken up via receptor-mediated mechanisms do not seem to be a significant source of T3 and T4 production.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [67] Marinò, 2000, Role of thyroglobulin endocytic pathways in the control of thyroid hormone release, Am J Physiol Cell Physiol source
- Interpretationreasoning
For the HPT axis to sustain circulating free THs within the normal range, the regulation of TH synthesis and secretion by TSH in the thyroid gland plays a central role.
“For the HPT axis to sustain circulating free THs within the normal range, the regulation of TH synthesis and secretion by TSH in the thyroid gland plays a central role.”
Quote in the paperNot a substantial claim- Rests on an assumption: TSH stimulates the synthesis and secretion of T4 and T3 in the thyroid gland.
- Premisecitation
TPO utilizes H2O2 generated by DUOX/DUOXA to catalyze the oxidation of I- and subsequent iodination of tyrosine residues of soluble TG molecules nearby.
“TPO utilizes H2O2 generated by DUOX/DUOXA to catalyze the oxidation of I- and subsequent iodination of the tyrosine residues of soluble TG molecules nearby (60).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [60] Carvalho, 2017, Thyroid hormone biosynthesis and release, Mol Cell Endocrinol source
- Premisecitation
TSH can differentially activate Gαs and Gαq/11 in a concentration-dependent manner.
“TSH can differentially activate Gαs and Gαq/11 in a concentration-dependent manner (116).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [116] Allgeier, 1994, The human thyrotropin receptor activates G-proteins gs and Gq/11, J Biol Chem source
- Interpretationnone given
TSH is the most important regulator of TH synthesis and secretion by the thyroid gland.
“TSH is the most important regulator of TH synthesis and secretion by the thyroid gland.”
Quote in the paperNot a substantial claim- Rests on an assumption: TSH stimulates the synthesis and secretion of T4 and T3 in the thyroid gland.
- Premisecitation
When TG molecules in the colloid globule are needed, those on the outside, which are more recently iodinated, are hydrolyzed quickly, rather than the older ones packed inside.
“when the TG molecules in the colloid globule are needed to meet the TH demand, it is those on the outside of the globule, which are more recently iodinated, that are hydrolyzed quickly, rather than the ones packed inside, which are older and of greater iodothyronine content (83).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [83] Bagchi, 1980, Role of the heterogeneity of thyroglobulin in the secretion of thyroid hormone in mice, J Endocrinol source
- Interpretationreasoning
THs can regulate the activities and abundances of DIOs and certain UGTs in peripheral tissues in a feedback or feedforward manner to maintain their local levels.
“THs can regulate the activities and abundances of DIOs and certain UGTs in peripheral tissues in a feedback or feedforward manner to maintain their local levels.”
Quote in the paperSubstantial claim - Interpretationreasoning
Newer TG molecules are utilized first for TH production.
“Therefore, newer TG molecules are utilized first for TH production.”
Quote in the paperSubstantial claim - Interpretationreasoning
Feedforward appears to be the primary structure of the TTF regulatory network, in addition to autoregulatory loops.
“Feedforward appears to be the primary structure of the TTF regulatory network, in addition to autoregulatory loops ( Figure 2 ).”
Quote in the paperSubstantial claim - Premisecitation
PKC acts as a negative regulator of TH synthesis and secretion by inhibiting iodide organification.
“PKC acts as a negative regulator of TH synthesis and secretion by inhibiting iodide organification (129).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [129] Ginsberg, 1993, Enhancement of thyrotropin-stimulated iodide organification in porcine thyroid cells after protein kinase-c inhibition, Endocrinology source
- Interpretationreasoning
TSHR is under autoregulatory feedforward and feedback control by TSH.
“TSHR is under autoregulatory feedforward and feedback control by TSH ( Figure 3G ).”
Quote in the paperSubstantial claim - Premisecitation
TSH downregulates TTF1 mRNA and protein by inhibiting the promoter activity and transcription of TTF1 in FRTL-5 cells.
“TSH downregulates TTF1 mRNA and protein by inhibiting the promoter activity and transcription of TTF1 in FRTL-5 cells (155, 156).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [155] Saito, 1997, Thyroid-stimulating hormone-induced down-regulation of thyroid transcription factor 1 in rat thyroid FRTL-5 cells, Endocrinology source
- cites [156] Medina, 2000, Role of insulin and serum on thyrotropin regulation of thyroid transcription factor-1 and pax-8 genes expression in FRTL-5 thyroid cells, Thyroid source
- Premisecitation
In a microarray study using PCCl3 cells, TTF2 was downregulated significantly in the presence of a TTF1 inhibitor.
“In a microarray study using PCCl3 cells, TTF2 was downregulated significantly in the presence of a TTF1 inhibitor (151).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [151] Christophe-Hobertus, 2012, Functional inactivation of thyroid transcription factor-1 in PCCl3 thyroid cells, Mol Cell Endocrinol source
- Premisecitation
The Wolff-Chaikoff effect requires a high intracellular concentration of iodide of at least 1 mM.
“The Wolff–Chaikoff effect requires a high intracellular concentration (≥ 1 mM) of iodide (219).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [219] Bürgi, 2010, Iodine excess, Best Pract Res Clin Endocrinol Metab source
- Interpretationreasoning
TSH stimulates multiple G protein-mediated signal transduction pathways, which cross-talk or converge at various levels of the signaling cascade.
“In summary, TSH stimulates multiple G protein-mediated signal transduction pathways, which cross-talk or converge at various levels of the signaling cascade.”
Quote in the paperSubstantial claim - Premisecitation
TTF1 is the main transcriptional activator of the PDS promoter, controlling PDS expression in thyroid cells.
“TTF1 is the main transcriptional activator of the PDS promoter, controlling the expression of PDS in thyroid cells ( Figure 3D ) (171).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [171] Dentice, 2005, Pendrin is a novel in vivo downstream target gene of the TTF-1/Nkx-2.1 homeodomain transcription factor in differentiated thyroid cells, Mol Cell Biol source
- Interpretationcitation
The biphasic response to TSH may play an important role in the homeostatic control of thyroid gland size against gain-of-function mutations.
“By a similar token, the biphasic response to TSH may play an important role in the homeostatic control of the thyroid gland size against gain-of-function mutations.”
Quote in the paperNot a substantial claim - Premisecitation
Four TTFs are expressed in differentiated thyrocytes: TTF1, TTF2, PAX8, and HHEX.
“Four TTFs are expressed in differentiated thyrocytes: TTF1 (also known as NK2 homeobox 1, NKX2-1), TTF2 (also known as fork head box protein E1, FOXE1), paired box gene 8 (PAX8), and hematopoietically-expressed homeobox protein (HHEX) (141).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [141] Fernández, 2015, Thyroid transcription factors in development, differentiation and disease, Nat Rev Endocrinol source
- Premisecitation
It takes 10 times higher concentrations of TSH to activate Gαq/11 and the downstream phospholipase C (PLC) and inositol-1,4,5-trisphosphate (IP3) than to activate cAMP in human thyroid slices.
“It was reported that it takes 10 times higher concentrations of TSH to activate Gαq/11 and the downstream phospholipase C (PLC) and inositol-1,4,5-trisphosphate (IP3) than to activate cAMP in human thyroid slices (117).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [117] Laurent, 1987, Dual activation by thyrotropin of the phospholipase c and cyclic AMP cascades in human thyroid, Mol Cell Endocrinol source
- Interpretationcitation
The Plummer effect in rodents may not be as persistent as in humans.
“Therefore, the Plummer effect in rodents may not be as persistent as in humans.”
Quote in the paperNot a substantial claim - Interpretationreasoning
TTF1, TTF2, PAX8 and terminally activated TFs such as CREB converge on cis regulatory elements of target genes and regulate their expression in a feedforward fashion.
“The TTFs, mainly TTF1, TTF2 and PAX8, as well as the TFs terminally activated by the signal transduction pathways, such as CREB, converge on the cis regulatory elements of the above target genes and regulate their expression in a feedforward fashion ( Figure 3 ).”
Quote in the paperSubstantial claim - Interpretationreasoning
The TSH signal cascade diverges and converges at different nodes and layers to form interconnected coherent and/or incoherent feedforward controls.
“The divergence and convergence of these regulations primarily form interconnected, coherent and/or incoherent feedforward controls.”
Quote in the paperSubstantial claim - Interpretationcitation
In the cAMP/PKA/CREB pathway, CREB acts as a TF to directly regulate the gene expression of PAX8, TTF2, and TTF1.
“In the cAMP/PKA/CREB pathway, CREB acts as a TF to directly regulate the gene expression of PAX8, TTF2, and TTF1.”
Quote in the paperSubstantial claim - Interpretationcitation
TTF1 and PAX8 appear to act together to co-regulate many downstream genes including HHEX and TTF2.
“TTF1 and PAX8 appear to act together to co-regulate many downstream genes including HHEX and TTF2.”
Quote in the paperSubstantial claim - Premisecitation
PAX8 can bind to one site in the 5′-flanking regions of the TTF2 gene and activate its transcription in FRTL-5 cells.
“PAX8 can bind to one site in the 5′-flanking regions of the TTF2 gene and activate its transcription in FRTL-5 cells (150).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [150] D’Andrea, 2006, Functional inactivation of the transcription factor Pax8 through oligomerization chain reaction, Mol Endocrinol source
- Premisecitation
Activating the PLC/PKC pathway by using phorbol esters inhibited TTF1 and PAX8 expression in human Nthy-ori-3-1 thyrocytes.
“Huang et al. reported that activating the PLC/PKC pathway by using phorbol esters inhibited TTF1 and PAX8 expression in human Nthy-ori-3-1 thyrocytes (157).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [157] Huang, 2017, Iodinated TG in thyroid follicular lumen regulates TTF-1 and PAX8 expression via TSH/TSHR signaling pathway, J Cell Biochem source
- Interpretationreasoning
Starting from TTF1, mediated through PAX8, and ending on HHEX and TTF2, at least two coherent feedforward motifs are formed among the four TTFs.
“Taken together, starting from TTF1, mediated through PAX8, and ending on HHEX and TTF2, at least two coherent feedforward motifs are formed among the four TTFs ( Figure 2 ).”
Quote in the paperSubstantial claim - Interpretationreasoning
The intrathyroidal network involves multiple feedforward and feedback circuitries that are closely intertwined.
“It involves multiple feedforward and feedback circuitries that are closely intertwined ( Figure 6 ).”
Quote in the paperSubstantial claim - Premisecitation
The Degon et al. model was used to understand and predict the condition of dietary iodine deficiency and Wolff-Chaikoff phenomena.
“The model was used to understand and predict the condition of dietary iodine deficiency and Wolff-Chaikoff phenomena.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [276] Degon, 2008, A computational model of the human thyroid, Math Biosci source
- Interpretationreasoning
The structure of the intrathyroidal network is not linear and unidirectional.
“As in many other intracellular systems, the structure of the intrathyroidal network is not linear and unidirectional.”
Quote in the paperSubstantial claim - Interpretationnone given
Escaping from the Wolff-Chaikoff inhibition involves a negative feedback circuit whose function seems to maintain intracellular iodide homeostasis.
“Escaping from the inhibition involves a negative feedback circuit whose function seems to maintain intracellular iodide homeostasis.”
Quote in the paperNot a substantial claim - Premisecitation
TG accumulated in the follicular lumen regulates TH synthesis by suppressing thyroid-specific gene expression in a concentration-dependent manner.
“TG accumulated in the follicular lumen regulates TH synthesis by suppressing thyroid-specific gene expression in a concentration-dependent manner (247).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [247] Suzuki, 1999, Thyroglobulin regulates follicular function and heterogeneity by suppressing thyroid-specific gene expression, Biochimie source
- May combine two claims. 66
- Classified as probably not a substantial claim. 12
- The quote only partly states this claim. 3
May combine two claims.
PremisecitationT4 and rT3 inhibit DIO2 by promoting its ubiquitination, which inhibits DIO2 activity and targets it for proteasomal degradation, forming an incoherent feedforward motif with T3 as the output.
“T4 and rT3 also inhibit DIO2 by promoting its ubiquitination, which inhibits DIO2 activity and targets it for proteasomal degradation (37–40), forming an incoherent feedforward motif with T3 as the output.”
Quote in the paperSubstantial claim3 of 4 sources checked- cites [37] Steinsapir, 1998, Type 2 iodothyronine deiodinase in rat pituitary tumor cells is inactivated in proteasomes, J Clin Invest source
The Introduction identifies T4 and rT3 as D2 substrates that decrease its activity. The Results and Discussion show that rT3 accelerates D2 degradation through a proteasome-dependent pathway. The paper proposes ubiquitin conjugation as a possible step but does not demonstrate that T4 or rT3 promotes D2 ubiquitination. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [38] Gereben, 2000, Selective proteolysis of human type 2 deiodinase: a novel ubiquitin-proteasomal mediated mechanism for regulation of hormone activation, Mol Endocrinol source
- cites [39] Steinsapir, 2000, Substrate-induced down-regulation of human type 2 deiodinase (hD2) is mediated through proteasomal degradation and requires interaction with the enzyme’s active center, Endocrinology source
- cites [40] Sagar, 2007, Ubiquitination-induced conformational change within the deiodinase dimer is a switch regulating enzyme activity, Mol Cell Biol source
The introductory passage (page not provided) says T4 accelerates D2 ubiquitination, which inactivates D2 and targets it to the proteasome; the Results also report T4-induced loss of D2 activity. Our copy does not establish the same effect for rT3 (searched: rT3, reverse T3). The incoherent feedforward motif is the citing authors’ framing, not a finding attributed to this source. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationUptake of circulating I- by thyroid follicles is mediated by the Na+/I- symporter (NIS), a glycoprotein located on the basolateral plasma membrane of thyrocytes and encoded by SLC5A5.
“Uptake of circulating I- by thyroid follicles is mediated by the Na+/I- symporter (NIS), a glycoprotein located on the basolateral plasma membrane of the thyrocytes and encoded by the solute carrier family 5 member 5 (SLC5A5) gene (51).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [51] Ravera, 2017, The Sodium/Iodide symporter (NIS): Molecular physiology and preclinical and clinical applications, Annu Rev Physiol source
The Introduction states that NIS is a plasma-membrane glycoprotein that transports iodide into the thyroid. The Molecular Characterization and Iodide Transport Defect sections identify NIS as SLC5A5 and state that the SLC5A5 gene encodes it. Our copy does not specify that NIS is on the basolateral membrane of thyrocytes; its explicit basolateral examples concern other tissues. Page numbers are unavailable in the indexed copy. (LLM, conf=0.86)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationAbnormality in abundances or binding affinities of THBPs only results in changes in total, not free, THs in the blood, and patients are in most cases clinically euthyroid.
“abnormality in the abundances or binding affinities of THBPs only result in changes in the concentrations of total, not free, THs in the blood, and the patients are in most cases clinically euthyroid (28).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [28] Pappa, 2015, Inherited defects of thyroxine-binding proteins, Best Pract Res Clin Endocrinol Metab source
May combine two claims.
PremisecitationAn increase in serum T3 could upregulate DIO3 expression in the brain, increasing local T3 clearance, forming another local feedback control of T3.
“an increase in serum T3 could upregulate DIO3 expression in the brain, increasing local T3 clearance, forming another local feedback control of T3 (41–43).”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [41] Kaplan, 1980, Phenolic and tyrosyl ring deiodination of iodothyronines in rat brain homogenates, J Clin Invest source
The Results (p. 555) report that T3 degradation in cerebral-cortex homogenates was greatest in hyperthyroid rats, and the Discussion suggests that this activity could provide intracellular T3 disposal. The study does not show that a rise in serum T3 upregulates DIO3 expression or establish an in vivo feedback mechanism; the hyperthyroid rats were given T4. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [42] Esfandiari, 1992, Induction of type III deiodinase activity in astroglial cells by thyroid hormones, Endocrinology source
- cites [43] Becker, 1997, The type 2 and type 3 iodothyronine deiodinases play important roles in coordinating development in rana catesbeiana tadpoles, Endocrinology source
May combine two claims.
PremisecitationMore recently synthesized TG molecules, which are low or yet to be iodinated, tend to bind to membrane receptors including megalin and ASGPR and are internalized along with receptor recycling, while highly iodinated and sialylated TG molecules preferentially undergo nonspecific fluid pinocytosis.
“more recently synthesized TG molecules, which are low or yet to be iodinated, tend to bind to membrane receptors including megalin and ASGPR and are internalized along with receptor recycling, while highly iodinated and sialylated TG molecules preferentially undergo nonspecific fluid pinocytosis (68).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [68] Ulianich, 1999, Follicular thyroglobulin (TG) suppression of thyroid-restricted genes involves the apical membrane asialoglycoprotein receptor and TG phosphorylation, J Biol Chem source
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationDUOX2/DUOXA2 has higher enzymatic activities and is the predominant form in the thyroid compared to DUOX1/DUOXA1.
“Compared to DUOX1/DUOXA1, DUOX2/DUOXA2 has higher enzymatic activities and is the predominant form in the thyroid (57, 59).”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [57] Poncelet, 2019, The dual oxidase Duox2 stabilized with DuoxA2 in an enzymatic complex at the surface of the cell produces extracellular H(2)O(2) able to induce DNA damage in an inducible cellular model, Exp Cell Res source
- cites [59] Rigutto, 2009, Activation of dual oxidases Duox1 and Duox2: differential regulation mediated by camp-dependent protein kinase and protein kinase c-dependent phosphorylation, J Biol Chem source
The Discussion (page unavailable) proposes that Duox2 is the predominant thyroid enzyme, supporting that part of the claim. But the functional-assay section reports comparable specific activities for the two enzymes under one tested condition, while the Discussion reports greater Duox2 sensitivity to PMA—not generally higher enzymatic activity. (LLM, conf=0.89)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationFlotillin can physically interact with endocytosed TG and mediate the negative feedback of TG on TTFs.
“It can physically interact with endocytosed TG and mediate the negative feedback of TG on TTFs (90).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [90] Luo, 2016, A novel role for flotillin-containing lipid rafts in negative-feedback regulation of thyroid-specific gene expression by thyroglobulin, Thyroid source
The indexed Abstract reports that flotillins physically interact with endocytosed Tg and that disrupting flotillin-containing lipid rafts inhibits Tg’s negative-feedback effect on thyroid-specific gene expression. It does not specifically report an effect on TTFs (thyroid transcription factors), so that part of the claim is not established by the retrieved passage. (LLM, conf=0.85)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationMIT and DIT can be deiodinated by iodotyrosine dehalogenase (DEHAL), and the iodide released is recycled as a sustained source of intrathyroidal iodide for TH synthesis.
“These MIT and DIT can be deiodinated by iodotyrosine dehalogenase (DEHAL), and the iodide released is recycled as a sustained source of intrathyroidal iodide for TH synthesis (98, 99).”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [98] Gnidehou, 2004, Iodotyrosine dehalogenase 1 (DEHAL1) is a transmembrane protein involved in the recycling of iodide close to the thyroglobulin iodination site, FASEB J source
- cites [99] Solís, 2004, Comparative kinetic characterization of rat thyroid iodotyrosine dehalogenase and iodothyronine deiodinase type 1, J Endocrinol source
May combine two claims.
PremisecitationMCT10 seems to be dispensable as far as secreting TH is concerned since the thyroidal TH content is not elevated in MCT10 KO mice, whereas the thyroidal TH content accumulates to higher levels in MCT8 KO or MCT8/MCT10 double KO mice.
“MCT10 seems to be dispensable as far as secreting TH is concerned since the thyroidal TH content is not elevated in MCT10 KO mice, whereas the thyroidal TH content accumulates to higher levels in MCT8 KO or MCT8/MCT10 double KO mice (101, 105).”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [101] Trajkovic-Arsic, 2010, Impact of monocarboxylate transporter-8 deficiency on the hypothalamus-pituitary-thyroid axis in mice, Endocrinology source
- cites [105] Müller, 2014, Tissue-specific alterations in thyroid hormone homeostasis in combined Mct10 and Mct8 deficiency, Endocrinology source
May combine two claims.
PremisecitationMCT10 has a similar effect on transporting T3 to MCT8 but is less active toward T4, as demonstrated in COS1 cells transfected with human MCT10 cDNA.
“MCT10 has a similar effect on transporting T3 to MCT8 but is less active toward T4 than MCT8, as demonstrated in COS1 cells transfected with human MCT10 cDNA (103).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [103] Friesema, 2008, Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10, Mol Endocrinol source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationTPO catalyzes the coupling of MIT and DIT in the same TG molecule to produce intramolecular T3 and T4.
“TPO then further catalyzes the coupling of MIT and DIT in the same TG molecule to produce intramolecular T3 and T4 (66).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [66] Citterio, 2019, The role of thyroglobulin in thyroid hormonogenesis, Nat Rev Endocrinol source
The indexed copy identifies the cited review in repository metadata, but the substantive text returned is from a different paper about TSH genetics (Results; no page given). Searches for TPO, MIT, DIT, and iodotyrosine coupling found no passage from the cited review addressing the claimed intramolecular formation of T3 and T4, so the attribution cannot be verified from this copy. (LLM, conf=0.73)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationLow-concentration TSH binds to the high-affinity binding site on one of the protomers of the TSHR homodimer, and preferentially activates Gαs to stimulate cAMP accumulation, which then activates PKA.
“Low-concentration TSH binds to the high-affinity binding site on one of the protomers of the TSHR homodimer, and preferentially activates Gαs to stimulate cyclic adenosine monophosphate (cAMP) accumulation, which then activates protein kinase A (PKA) (120).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [120] Allen, 2011, Occupancy of both sites on the thyrotropin (TSH) receptor dimer is necessary for phosphoinositide signaling, FASEB J source
The Discussion (page not available) says TSH binding at the high-affinity site on one TSHR homodimer protomer favors Gs activation and stimulates cAMP production; the Results also show cAMP signaling at lower TSH concentrations than phosphoinositide signaling. Our copy does not state that the resulting cAMP activates PKA, so that final step is not supported by this source. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationTSH binding to TSHR activates signal transduction pathways that regulate TTF activities, which in turn control expression of thyroid-specific functional proteins including NIS, pendrin, TG, TPO, DUOX(A)1/2, DIO1 and DIO2, participating in TH synthesis and secretion.
“Binding of TSH to TSHR activates signal transduction pathways that regulate TTF activities, which in turn control the gene expression of many thyroid-specific functional proteins, including NIS, pendrin, TG, TPO, DUOX(A)1/2, DIO1 and DIO2, that participate in the synthesis and secretion of THs (158, 159).”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [158] Kambe, 1997, Thyroid-specific transcription factors, Endocr J source
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites [159] Pellizzari, 2000, Expression and function of the homeodomain-containing protein hex in thyroid cells, Nucleic Acids Res source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationHHEX promoter activity could be increased by 3~4 fold by TTF1 in rat FRTL-5 thyroid cells and by PAX8 in transfected Hela cells.
“The HHEX promoter activity could be increased by 3~4 fold by TTF1 in rat FRTL-5 thyroid cells (146) and by PAX8 in transfected Hela cells (147).”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [146] Puppin, 2003, Thyroid-specific transcription factors control hex promoter activity, Nucleic Acids Res source
Citation (147) is attached to the PAX8 effect in transfected HeLa cells; the TTF-1 clause has a separate citation. Our copy’s Introduction mentions Pax8, but its Results on Hex promoter activation in HeLa cells test TTF-1 and Hex protein, not PAX8. A search for PAX8-mediated Hex promoter activation found no passage establishing the attributed effect. (LLM, conf=0.75)
Experimental — accuracy not yet measured - cites [147] Puppin, 2004, Functional interaction among thyroid-specific transcription factors: Pax8 regulates the activity of hex promoter, Mol Cell Endocrinol source
May combine two claims.
PremisecitationPAX8 and TTF1 activate the TG promoter and interact directly to form a functional complex responsible for synergistic transcriptional activation of the TG promoter.
“PAX8 and TTF1 are able to interact directly in vitro and form a functional complex in vivo responsible for the synergistic transcriptional activation of the TG promoter (145).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [145] Di Palma, 2003, The paired domain-containing factor Pax8 and the homeodomain-containing factor TTF-1 directly interact and synergistically activate transcription, J Biol Chem source
May combine two claims.
PremisecitationTTF1 and PAX8 activate TPO transcription by binding to overlapping DNA sites in the promoter, and TTF2 may interfere with their binding to inhibit TPO transcriptional activation.
“TTF1 and PAX8 can activate the transcription of TPO by binding to specific DNA binding sites that overlap each other in the promoter region ( Figure 3C ) (169).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [169] Zannini, 1992, Pax-8, a paired domain-containing protein, binds to a sequence overlapping the recognition site of a homeodomain and activates transcription from two thyroid-specific promoters, Mol Cell Biol source
May combine two claims.
PremisecitationThe Wolff-Chaikoff effect is a transient inhibition of iodide organification and TH synthesis caused by high iodide, lasting approximately 26-50 h in rats and followed by escape despite ongoing iodine excess.
“The inhibition is transient, lasting approximately 26-50 h in rats, followed by adaption and escape of the thyroid from the inhibition despite ongoing iodine excess – the organification of intrathyroidal iodide resumes and TH synthesis returns to near normal levels (207, 208).”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [207] Wolff, 1949, The temporary nature of the inhibitory action of excess iodine on organic iodine synthesis in the normal thyroid, Endocrinology source
- cites [208] Braverman, 1963, Changes in thyroidal function during adaptation to large doses of iodide, J Clin Invest source
The opening paragraph (page not provided) says that inhibition of organic binding abated and hormone formation resumed in rats despite maintained high plasma iodide; the Summary (page not provided) also describes escape during prolonged iodide administration. Our copy does not give the claimed 26–50-hour duration or say that thyroid-hormone synthesis returned to near-normal levels. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationAbolishing PAX8 downregulates DIO1 expression in thyroid cells, suggesting PAX8 activates DIO1 transcriptionally, likely mediated by the selenocysteine insertion sequence in the 3' UTR of DIO1.
“Abolishing PAX8 downregulated DIO1 expression in thyroid cells, suggesting that PAX8 activates DIO1 transcriptionally, which is likely mediated by the selenocystein insertion sequence in the 3’ untranslated region of the DIO1 gene (178).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [178] Ruiz-Llorente, 2012, Genome-wide analysis of Pax8 binding provides new insights into thyroid functions, BMC Genomics source
The Discussion ('Identification of biological processes controlled by Pax8 in thyroid cells'; page unavailable) reports DIO1 downregulation after Pax8 abolition and potential Pax8 binding near a region important for selenocysteine insertion. The Results describe Dio1 among validated targets with reduced expression after Pax8 silencing. But the paper does not establish that transcriptional activation is mediated by a sequence in the DIO1 3′ UTR; the Discussion instead cites preliminary evidence for Pax8-dependent DIO1 mRNA stabilization. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationMCT8 and TSHR form a heterodimeric complex that directly modulates the selectivity of TSHR-mediated signal transduction pathways, with MCT8 profoundly reducing TSH-induced Gαq/11 signaling without affecting Gαs-mediated cAMP accumulation.
“The two can form heterodimeric complex which directly modulates the selectivity of TSHR-mediated signal transduction pathways. MCT8 profoundly reduces the capacity of TSH to induce Gαq/11-mediated signaling at TSHR, without affecting Gαs-mediated cAMP accumulation (196).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [196] Fischer, 2018, Evidence of G-protein-coupled receptor and substrate transporter heteromerization at a single molecule level, Cell Mol Life Sci source
The Results (page not supplied) report a 60–70% reduction in the IP3 measure of Gq/11 signaling with MCT8 co-expression, while the slight reduction in TSH-induced cAMP accumulation was not statistically significant. The Discussion (page not supplied) says the TSHR/MCT8 complex *could* directly modulate pathway selectivity and leaves its exact heteromeric nature for future study; the claim presents direct modulation and a heterodimeric complex as established. (LLM, conf=0.86)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationThe DIO2 promoter contains both a CREB-binding site and a TTF1 binding site, and TSH and TTF1 upregulate DIO2 activity.
“The promoter of the DIO2 gene contains both CREB-binding site and TTF1 binding site, and TSH and TTF1 were shown to upregulate DIO2 activity ( Figure 3F ) (176, 177).”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [176] Bartha, 2000, Characterization of the 5’-flanking and 5’-untranslated regions of the cyclic adenosine 3’,5’-monophosphate-responsive human type 2 iodothyronine deiodinase gene, Endocrinology source
- cites [177] Gereben, 2001, The human, but not rat, dio2 gene is stimulated by thyroid transcription factor-1 (TTF-1), Mol Endocrinol source
The Discussion reports a functional CRE and TTF-1 binding sites in the human DIO2 promoter, and the promoter-response results show that TTF-1 increases its transcriptional activity. The paper does not show that TSH upregulates DIO2 activity; its rat-thyroid results instead report lower D2 mRNA after TSH stimulation. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationIodine organification and TH secretion in response to TSH are severely reduced in thyrocyte-specific Gαq/11-deficient mice which often develop hypothyroidism after birth.
“Iodine organification and TH secretion in response to TSH are severely reduced in thyrocyte-specific Gαq/11-deficient mice which often develop hypothyroidism after birth (131).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [131] Kero, 2007, Thyrocyte-specific Gq/G11 deficiency impairs thyroid function and prevents goiter development, J Clin Invest source
May combine two claims.
PremisecitationMCT10 plays an important role in maintaining TSHR at the basolateral plasma membrane of thyrocytes; in murine models lacking MCT10, TSHR localization is restricted to vesicles.
“Besides, MCT10 plays an important role in maintaining TSHR at the basolateral plasma membrane of the thyrocytes. In murine models lacking MCT10, the localization of TSHR is restricted to vesicles (197).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [197] Venugopalan, 2021, The amino acid transporter Mct10/Tat1 is important to maintain the TSH receptor at its canonical basolateral localization and assures regular turnover of thyroid follicle cells in Male mice, Int J Mol Sci source
Results §2.2 reports that Mct10−/− thyrocytes have TSH receptors exclusively in vesicles, supporting MCT10’s role in maintaining basolateral localization. But the claim is too broad for all murine models lacking MCT10: the same section reports that additional cathepsin K deficiency maintains basolateral TSH receptor localization. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationTSH can increase the half-life of NIS protein and plasma membrane translocation, possibly mediated by TSH-stimulated NIS phosphorylation.
“It has been demonstrated that TSH can increase the half-life of NIS protein and plasma membrane translocation, which may be mediated by TSH-stimulated NIS phosphorylation (165).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [165] Riedel, 2001, Post-transcriptional regulation of the sodium/iodide symporter by thyrotropin, J Biol Chem source
The Results report that NIS half-life was approximately 5 days with TSH versus 3 days without it, and that TSH regulates NIS distribution at the cell surface. The Discussion says TSH is required for targeting NIS to and/or retaining it at the plasma membrane, but explicitly leaves those possibilities unresolved. It also shows TSH-dependent phosphorylation changes while treating a role for phosphorylation in targeting as a question for future investigation, not an established mechanism. (LLM, conf=0.86)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationIn human thyroid tissues, the mRNAs of TTF1 and HHEX were found to be positively correlated and so were the mRNAs of PAX8 and HHEX.
“In human thyroid tissues, the mRNAs of TTF1 and HHEX were found to be positively correlated (146) and so were the mRNAs of PAX8 and HHEX (147).”
Quote in the paperSubstantial claim1 of 2 sources checkedMay combine two claims.
PremisecitationHHEX binds to the TG promoter and functions as a repressor to abolish the activating effects of both TTF1 and PAX8 in FRTL-5 cells.
“HHEX can bind to the TG promoter and function as a repressor to abolish the activating effects of both TTF1 and PAX8 in FRTL-5 cells (159).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [159] Pellizzari, 2000, Expression and function of the homeodomain-containing protein hex in thyroid cells, Nucleic Acids Res source
The Results (p. 2506) report that Hex abolishes both TTF-1 and Pax8 activation of the Tg promoter, and the Discussion describes Hex as a Tg-promoter repressor. But the Methods place the TTF-1/Pax8 co-transfection experiments in HeLa cells; the FRTL-5 experiment tested Hex-mediated repression, not abolition of both factors’ activating effects. The binding assays used Tg-promoter sequences (Fig. 6, p. 2509). (LLM, conf=0.93)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationTTF1 and Pax8 are able to interact directly, as demonstrated in rat PCCl3 thyrocytes in vitro, thus they may form a functional protein complex driving synergistic transcriptional activation of target genes such as TG.
“TTF1 and Pax8 are able to interact directly, as demonstrated in rat PCCl3 thyrocytes in vitro, thus they may form a functional protein complex driving synergistic transcriptional activation of target genes such as TG (145).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [145] Di Palma, 2003, The paired domain-containing factor Pax8 and the homeodomain-containing factor TTF-1 directly interact and synergistically activate transcription, J Biol Chem source
May combine two claims.
PremisecitationPKC phosphorylates DUOX2 and induces its H2O2-generating activity, while PKA-mediated phosphorylation of serine 955 of DUOX1 stimulates its activity.
“PKC can phosphorylate DUOX2 and induce its H2O2-generating activity, while PKA-mediated phosphorylation of serine 955 of DUOX1 can stimulate its activity (59).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [59] Rigutto, 2009, Activation of dual oxidases Duox1 and Duox2: differential regulation mediated by camp-dependent protein kinase and protein kinase c-dependent phosphorylation, J Biol Chem source
May combine two claims.
PremisecitationHigh-concentration TSH binds to both the high- and low-affinity protomers, activating both Gαs and Gαq/11 to increase cAMP production and activate PKC, respectively.
“High-concentration TSH binds to both the high- and low-affinity protomers, activating both Gαs and Gαq/11 to increase cAMP production and activate PKC, respectively (120).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [120] Allen, 2011, Occupancy of both sites on the thyrotropin (TSH) receptor dimer is necessary for phosphoinositide signaling, FASEB J source
The Discussion states that TSH occupancy of both the high- and low-affinity sites permits Gs and Gq/11 activation, increasing cAMP and IP1 production. The paper describes phosphoinositide signaling through Gq/11 but does not report PKC activation; that part of the attributed claim is unsupported. (LLM, conf=0.89)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationPositive autoregulatory loops exist for TTF1, PAX8 and HHEX.
“Lastly, positive autoregulatory loops also exist for TTF1 (152), PAX8 (150) and HHEX (146).”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [152] Oguchi, 1998, Multiple transcripts encoded by the thyroid-specific enhancer-binding protein (T/EBP)/thyroid-specific transcription factor-1 (TTF-1) gene: evidence of autoregulation, Endocrinology source
- cites [150] D’Andrea, 2006, Functional inactivation of the transcription factor Pax8 through oligomerization chain reaction, Mol Endocrinol source
- cites [146] Puppin, 2003, Thyroid-specific transcription factors control hex promoter activity, Nucleic Acids Res source
May combine two claims.
InterpretationreasoningThe negative feedback of TG autoregulation may act as an oscillator that drives cyclic follicular function and renders follicle heterogeneity.
“The follicle heterogeneity may also result from the operation of the negative feedback of TG autoregulation, which may cause cyclic changes in each follicle’s function, termed as thyroid follicular cycle (257, 270).”
Quote in the paperSubstantial claim1 of 2 sources checkedMay combine two claims.
PremisecitationIodide overload decreases MCT8 mRNA and protein expression in rats, thus reducing T4 and T3 secretion into the blood stream.
“Lastly, iodide overload decreased MCT8 mRNA and protein expression in rats, thus reducing T4 and T3 secretion into the blood stream (102, 215).”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [102] de Souza, 2015, MCT8 is downregulated by short time iodine overload in the thyroid gland of rats, Horm Metab Res source
- cites [215] Lebsir, 2018, Effects of repeated potassium iodide administration on genes involved in synthesis and secretion of thyroid hormone in adult male rat, Mol Cell Endocrinol source
The Discussion (p. 18) reports that MCT8 mRNA decreased one day after KI administration in rats, but attributes the MCT8 protein finding to de Souza et al. (2015), rather than measuring it in this study. The Discussion (p. 19) says thyroid hormone levels were unchanged, so this paper does not establish the claimed reduction of T4 and T3 in the bloodstream. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe intrathyroidal T4-to-T3 conversion driven by TSH-stimulated DIO2 induction was explored for its role in circadian secretion of T3.
“The intrathyroidal T4-to-T3 conversion driven by TSH-stimulated DIO2 induction was explored for its role in circadian secretion of T3 (180).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [180] Berberich, 2018, Mathematical modeling of the pituitary-thyroid feedback loop: Role of a TSH-T(3)-Shunt and sensitivity analysis, Front Endocrinol (Lausanne) source
The model description says it explores TSH-stimulated intrathyroidal T4-to-T3 conversion, and the Conclusion and Outlook links intrathyroidal T3 secretion to a circadian FT3 pattern. But the Dynamic Simulation section does not identify TSH-induced DIO2 as the driver: type 2 deiodination contributes only 0.002% of modeled thyroidal T3 secretion and is described as negligible. Page numbers are not available in our copy. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationMany models focus on various aspects of the HPT axis, but models that specifically simulate the molecular regulations in thyroid follicles are still uncommon.
“While there are many models focusing on various aspects of the HPT axis (180, 273–275), models that specifically simulate the molecular regulations in thyroid follicles are still uncommon.”
Quote in the paperSubstantial claim2 of 4 sources checked- cites [180] Berberich, 2018, Mathematical modeling of the pituitary-thyroid feedback loop: Role of a TSH-T(3)-Shunt and sensitivity analysis, Front Endocrinol (Lausanne) source
- cites [273] Saratchandran, 1976, An improved mathematical model of human thyroid hormone regulation, Clin Endocrinol (Oxf) source
- cites [274] Liu, 1994, A new mathematical model of hypothalamo-pituitary-thyroid axis, Math Comput Model source
- cites [275] Eisenberg, 2008, Extensions, validation, and clinical applications of a feedback control system simulator of the hypothalamo-pituitary-thyroid axis, Thyroid source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCohen et al. used a bioinformatic approach to map out a regulatory network underpinning the Wolff-Chaikoff phenomena, with the goal of predicting the protective effect of repetitive dosing of iodide as a prophylactic measure.
“More recently, Cohen et al. has used a bioinformatic approach to map out a regulatory network underpinning the Wolff-Chaikoff phenomena, with the goal of predicting the protective effect of repetitive dosing of iodide as a prophylactic measure (277).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [277] Cohen, 2019, A systems biology approach to propose a new mechanism of regulation of repetitive prophylaxis of stable iodide on sodium/iodide symporter (NIS), Biochimie source
The Abstract and Materials and methods describe a systems-biology network used to investigate Wolff–Chaikoff regulation during repetitive potassium iodide administration. But the paper states its aim was to explain observed gene-expression changes and propose a mechanism of NIS regulation, not to predict the protective effect of repeated prophylactic dosing. Page numbers are unavailable in our copy. (LLM, conf=0.87)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationHigh iodide downregulates NIS through inhibition of NIS transcription, shortening of NIS mRNA poly(A) tail and destabilization, and shortening of NIS protein half-life.
“NIS is downregulated by high iodide through several mechanisms. First of all, high iodide inhibits the transcription of NIS (216, 234, 235).”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [216] Eng, 1999, Escape from the acute Wolff-chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein, Endocrinology source
- cites [234] Eng, 2001, Regulation of the sodium iodide symporter by iodide in FRTL-5 cells, Eur J Endocrinol source
- cites [235] Leoni, 2008, Differential gene expression analysis of iodide-treated rat thyroid follicular cell line PCCl3, Genomics source
The Validation of SAGE data section reports that high iodide reduced Nis mRNA expression in PCCl3 cells, supporting NIS downregulation. The paper does not establish that inhibition of NIS transcription, rather than another mechanism affecting mRNA abundance, caused the reduction. The poly(A)-tail and protein-half-life mechanisms are not part of the quoted citing sentence assessed here. (LLM, conf=0.87)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Interpretationnone givenMany of the regulations reviewed are based on in vitro and in vivo studies in a variety of species, particularly rat thyroid cell lines, thus caution should be exercised when generalization is made.
“many of the regulations reviewed here are based on in vitro and in vivo studies in a variety of species, particularly rat thyroid cell lines, thus caution should be exercised when generalization is made.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThe effects of TSH are mediated by the thyrotropin receptor (TSHR), which belongs to a family of GPCRs and is located at the basolateral plasma membrane of the thyrocytes.
“The effects of TSH are mediated by the thyrotropin receptor (TSHR) which belongs to a family of GPCRs and is located at the basolateral plasma membrane of the thyrocytes (107).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [107] Rapoport, 1998, The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies, Endocr Rev source
May combine two claims.
PremisecitationT3 represses gene transcription of DIO2, forming a negative feedback loop to keep intracellular T3 within a range.
“T3 can repress the gene transcription of DIO2, the primary activating enzyme that converts T4 into T3, therefore forming a negative feedback loop to keep intracellular T3 within a range (30–32).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [30] Kim, 1998, Studies of the hormonal regulation of type 2 5’-iodothyronine deiodinase messenger ribonucleic acid in pituitary tumor cells using semiquantitative reverse transcription-polymerase chain reaction, Endocrinology source
- cites [31] Hosoi, 1999, Expression and regulation of type II iodothyronine deiodinase in cultured human skeletal muscle cells, J Clin Endocrinol Metab source
- cites [32] Bianco, 2019, Paradigms of dynamic control of thyroid hormone signaling, Endocr Rev source
May combine two claims.
PremisecitationTHBPs serve as a reservoir to buffer free T4 and T3 concentrations against transient fluctuations and ensure steady delivery of THs through target tissues.
“the THBPs serve as a reservoir to buffer free T4 and T3 concentrations against transient fluctuations and ensure steady delivery of THs through the target tissues (26, 27).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationANO1 is a calcium-activated chloride channel that mediates I- efflux across the apical membrane of thyrocytes.
“ANO1 is a calcium-activated chloride channel, which has been demonstrated to mediate I- efflux across the apical membrane of thyrocytes (54).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [54] Twyffels, 2014, Anoctamin-1/TMEM16A is the major apical iodide channel of the thyrocyte, Am J Physiol Cell Physiol source
May combine two claims.
PremisecitationTG storage in the colloid makes TG highly enriched in the lumen, reaching a concentration as high as nearly 600 mg/ml in the human thyroid gland, and constituting >95% of the colloid protein content.
“This unique storage mechanism makes TG highly enriched in the lumen, reaching a concentration as high as nearly 600 mg/ml in the human thyroid gland, and constituting >95% of the colloid protein content (67, 78–80).”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [67] Marinò, 2000, Role of thyroglobulin endocytic pathways in the control of thyroid hormone release, Am J Physiol Cell Physiol source
- cites [78] Hayden, 1970, Micropuncture investigation of the anion content of colloid from single rat thyroid follicles. a micromethod for the simultaneous determination of iodide and chloride in nanomole quantities, Pflugers Arch source
- cites [79] Smeds, 1972, A microgel electrophoretic analysis of the colloid proteins in single rat thyroid follicles. II. the protein concentration of the colloid single rat thyroid follicles, Endocrinology source
- cites [80] Berndorfer, 1996, Multimerization of thyroglobulin (TG) during extracellular storage: isolation of highly cross-linked TG from human thyroids, J Clin Endocrinol Metab source
May combine two claims.
PremisecitationIn human blood, nearly 99.97% of T4 and 99.70% of T3 are bound to specific THBPs.
“nearly 99.97% of T4 and 99.70% of T3 are bound to specific THBPs (22)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [22] Mendel, 1989, The free hormone hypothesis: a physiologically based mathematical model, Endocr Rev source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationFeedback and feedforward are key network motifs that underpin dynamic behaviors including signal amplification, multistability, adaptation, homeostasis, oscillation, fold-change detection, signaling delay and acceleration, threshold and nonmonotonic effect.
“Feedback and feedforward are key network motifs that underpin a variety of dynamic behaviors, including signal amplification, multistability, adaptation, homeostasis, oscillation, fold-change detection, signaling delay and acceleration, threshold and nonmonotonic effect etc. (48, 49).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationMCT8 favors T4 secretion over T3 secretion, as demonstrated by the higher-than-normal T3/T4 ratio in MCT8 KO mice and in patients with MCT8 mutation.
“MCT8 favors T4 secretion over T3 secretion, as demonstrated by the higher-than-normal T3/T4 ratio in MCT8 KO mice and in patients with MCT8 mutation (101, 102).”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationA human TG molecule contains on average 2.28 molecules of T4 and 0.29 molecules of T3.
“A human TG molecule contains on average 2.28 molecules of T4 and 0.29 molecules of T3 (67).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [67] Marinò, 2000, Role of thyroglobulin endocytic pathways in the control of thyroid hormone release, Am J Physiol Cell Physiol source
May combine two claims.
PremisecitationUnder circumstances such as iodine deprivation or TSH overstimulation, the colloid TG globule is solubilized by proteinases and the solubilized TG is taken up by thyrocytes.
“Under circumstances such as iodine deprivation or TSH overstimulation, the colloid TG globule will be solubilized by proteinases and the solubilized TG will be taken up by thyrocytes (67).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [67] Marinò, 2000, Role of thyroglobulin endocytic pathways in the control of thyroid hormone release, Am J Physiol Cell Physiol source
May combine two claims.
PremisecitationThe close proximity between DUOX and TPO makes newly produced H2O2 readily captured by TPO and reduces potential oxidative damage by H2O2.
“The close proximity between DUOX and TPO makes newly produced H2O2 readily captured by TPO and reduces potential oxidative damage by H2O2 that would otherwise diffuse afar (64, 65).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationTAAR1 can co-localize with cathepsins B and L and regulate the proteolytic action of these cysteine cathepsins and internalization of TG.
“TAAR1 can co-localize with cathepsins B and L and regulate the proteolytic action of these cysteine cathepsins and internalization of TG (77).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [77] Brix, 2020, Auto-regulation of the thyroid gland beyond classical pathways, Exp Clin Endocrinol Diabetes source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe active uptake of I- by NIS is Na+-dependent, coupling energy from inward Na+ translocation to inward I- translocation against its electrochemical gradient.
“The active uptake of I- by NIS is Na+-dependent, which couples the energy released by the inward translocation of Na+ down its chemical gradient to the simultaneous inward translocation of I- against its electrochemical gradient (52).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [52] Rousset, 2000, Thyroid hormone synthesis and secretion
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe positive and negative regulations of TSHR by TSH and cAMP form an incoherent feedforward control that is likely important for TSHR homeostasis and receptor desensitization.
“While likely important for TSHR homeostasis and receptor desensitization, the positive and negative regulations of TSHR by TSH and cAMP form an incoherent feedforward control.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThe Plummer effect is more prominent in hyperthyroid patients but also occurs, to a lesser degree, in euthyroid individuals.
“The Plummer effect is more prominent in hyperthyroid patients but also occurs, to a less degree, in euthyroid individuals (214).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [214] Phillppou, 1992, The effect of iodide on serum thyroid hormone levels in normal persons, in hyperthyroid patients, and in hypothyroid patients on thyroxine replacement, Clin Endocrinol source
May combine two claims.
PremisecitationIn FRTL-5 thyroid cells, TSH treatment first upregulates TSHR mRNA moderately in the initial 2 hours and then downregulates it by 75%, with mRNA recovering in 6 days after TSH withdrawal.
“In FRTL-5 thyroid cells, TSH treatment first upregulated TSHR mRNA moderately in the initial 2 hours and then downregulated it by 75%, and the mRNA recovered in 6 days after TSH withdrawal (188, 189).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [188] Akamizu, 1990, Cloning, chromosomal assignment, and regulation of the rat thyrotropin receptor: expression of the gene is regulated by thyrotropin, agents that increase cAMP levels, and thyroid autoantibodies, Proc Natl Acad Sci U.S.A. source
- cites [189] Saji, 1992, Regulation of thyrotropin receptor gene expression in rat FRTL-5 thyroid cells, Endocrinology source
May combine two claims.
InterpretationreasoningThe inhibitory effect of high iodine involves blockade of multiple molecular events in TH synthesis and secretion, including iodide organification, proteolysis of iodinated TG to liberate T4 and T3, and release of T4 and T3 into the blood stream.
“The inhibition involves blockade of multiple molecular events in the sequential processes of TH synthesis and secretion, including iodide organification, proteolysis of iodinated TG to liberate T4 and T3, and release of T4 and T3 into the blood stream ( Figure 4A ).”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThese TTFs play critical roles in thyroid differentiation and coordinately regulate the suite of functional genes involved in TH synthesis.
“These TTFs play critical roles in thyroid differentiation and also coordinately regulate the suite of functional genes involved in TH synthesis (142).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [142] Suzuki, 1998, Autoregulation of thyroid-specific gene transcription by thyroglobulin, Proc Natl Acad Sci U.S.A. source
May combine two claims.
InterpretationreasoningThe physiological function of cAMP signaling activated via Gαs is to promote TH synthesis, thyrocyte growth and proliferation.
“Thus, the physiological function of cAMP signaling activated via Gαs is to promote TH synthesis, thyrocyte growth and proliferation.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationThe incoherent feedforward motif formed by Gαs and Gαi/o is responsible for the biphasic cAMP response and likely for similar downstream gene expression responses.
“Therefore, the incoherent feedforward motif formed by Gαs and Gαi/o ( Figure 1 ) is responsible for the biphasic cAMP response and, likely, similar downstream gene expression responses.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningThese cross-regulations can be either stimulatory or inhibitory, forming tiered, coherent or incoherent feedforward motifs.
“These cross-regulations can be either stimulatory or inhibitory, forming tiered, coherent or incoherent feedforward motifs ( Figure 1 ).”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationPAX8 binds to the 5'-flanking region of DUOX2 to activate its transcription, while TTF2 binds to the DUOX2 promoter but represses its transcription.
“PAX8 can bind to the 5′-flanking region of the DUOX2 gene to activate its transcription ( Figure 3E ) (150).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [150] D’Andrea, 2006, Functional inactivation of the transcription factor Pax8 through oligomerization chain reaction, Mol Endocrinol source
May combine two claims.
InterpretationreasoningWith CREB added to the top of the TTF network, more feedforward motifs are formed, including incoherent ones through the inhibition of TTF1 by CREB.
“With CREB added to the top of the TTF network, more feedforward motifs are formed, including incoherent ones through the inhibition of TTF1 by CREB ( Figure 2 ).”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningMCT8, by heterodimerizing with TSHR and interfering with Gαq/11 signaling, may inhibit T3/T4 release, while the long-term stimulatory effect of TSH mediated by Gαs is spared.
“Since Gαq/11 is involved through calcium signaling in the cleavage of T3 and T4 from TG by cathepsins and their release as an acute effect (77, 130), MCT8, by heterodimerizing with TSHR and interfering with Gαq/11 signaling, may inhibit T3/T4 release, while the long-term stimulatory effect of TSH mediated by Gαs is spared.”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
InterpretationreasoningNegative feedback regulatory pathways operate on top of the feedforward backbone and provide important functions to thyroid homeostasis.
“As revealed below, a number of negative feedback regulatory pathways also operate on top of the feedforward backbone, providing important functions to thyroid homeostasis.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationTTF1, TTF2, and PAX8 can bind to upstream enhancer and promoter regions of NIS and stimulate its transcriptional activity.
“TTF1, TTF2, and PAX8 can bind to the upstream enhancer and promoter regions of NIS and stimulate its transcriptional activity ( Figure 3A ).”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningIodide regulates TH synthesis in an incoherent feedforward manner because iodide is required for TH synthesis and high iodide inhibits TH synthesis.
“Since iodide is required for TH synthesis and high iodide inhibits TH synthesis through the mechanisms detailed below, it follows that iodide regulates TH synthesis in an incoherent feedforward manner ( Figure 4B , top half involving red line).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based).
Interpretationnone givenMultiple incoherent feedforward motifs formed by signal transduction pathways, TTFs and thyroid functional genes may be responsible for the biphasic response of the thyroid to TSH.
“For instance, the multiple incoherent feedforward motifs formed by the signal transduction pathways, TTFs and thyroid functional genes may be responsible for the biphasic response of the thyroid to TSH.”
Quote in the paperNot a substantial claimMay combine two claims. The quote only partly states this claim.
PremisecitationIodolipid 2-IHDA is believed to play a major role in mediating the Wolff-Chaikoff inhibitory effect by inhibiting H2O2 production and TPO/TG expression.
“Iodolipid, such as 2-iodohexadecanal (2-IHDA), is believed to play a major role in mediating the Wolff-Chaikoff inhibitory effect.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationThe Plummer effect is believed to result from reduced proteolytic cleavage of iodinated TG to liberate T4 and T3 and inhibition of TH secretion from thyrocytes, forming another incoherent feedforward motif.
“This is believed to result from reduction of the proteolytic cleavage of iodinated TG to liberate T4 and T3 and inhibition of TH secretion from the thyrocytes (226), which form another incoherent feedforward motif ( Figure 4B , top half involving blue line).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [226] Koukkou, 2017, Effect of excess iodine intake on thyroid on human health, Minerva Med source
May combine two claims.
Premisenone givenThe incoherent feedforward motif driven by iodide is responsible for TH synthesis at normal conditions and the Wolff-Chaikoff inhibition under high iodine load.
“The incoherent feedforward motif driven by iodide is responsible for the TH synthesis at normal conditions and the Wolff-Chaikoff inhibition under high iodine load.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationHighly iodinated TG suppresses TTF1 and PAX8 expression at both mRNA and protein levels, likely mediated by augmented PKC and suppressed PKA activities.
“Highly iodinated TG suppressed TTF1 and PAX8 expression at both mRNA and protein levels, which is likely mediated by augmented PKC and suppressed PKA activities (157).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [157] Huang, 2017, Iodinated TG in thyroid follicular lumen regulates TTF-1 and PAX8 expression via TSH/TSHR signaling pathway, J Cell Biochem source
May combine two claims. The quote only partly states this claim.
InterpretationreasoningTG-mediated feedback appears to inhibit processes leading to accumulation of iodinated TG and promote TG lysosomal degradation and TH release, and may function to maintain homeostasis of iodinated TG rather than THs.
“Therefore, the TG-mediated feedback may function to maintain the homeostasis of iodinated TG, rather than THs.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S2 (checkable).
PremisecitationA better understanding of complex pathways requires formulation of mathematical models to simulate the network as nonlinear dynamical systems.
“A better understanding of complex pathways as such requires formulation of mathematical models to simulate the network as nonlinear dynamical systems (49).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [49] El-Samad, 2021, Biological feedback control–respect the loops, Cell Syst source
Probably not a substantial claim: may not pass S4 (based).
InterpretationreasoningDysregulation of the intrathyroidal molecular network, internally or externally by exogenous disruptors, can lead to pathological thyroid conditions including goiter, hypothyroidism, hyperthyroidism, and thyroid cancers.
“Dysregulation of this network, either internally or externally by exogenous disruptors, can lead to pathological thyroid conditions, including goiter, hypothyroidism, hyperthyroidism, and thyroid cancers.”
Quote in the paperNot a substantial claim- Rests on an assumption: The intrathyroidal molecular network described is sufficient to explain thyroid hormone homeostasis under physiological and pathological conditions.
May combine two claims.
InterpretationcitationA potential oscillatory behavior resulting from TG-mediated negative feedback regulation may lead to cyclic follicular function and underpin the observed follicular heterogeneity.
“A potential oscillatory behavior resulting from TG-mediated negative feedback regulation may lead to cyclic follicular function and underpin the observed follicular heterogeneity (257).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [257] Sellitti, 2014, Intrinsic regulation of thyroid function by thyroglobulin, Thyroid source
Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).
Interpretationnone givenSystems biology models can incorporate genetic, epigenetic, environmental and nutritional status to better predict responses of individuals.
“Such systems biology models can incorporate genetic, epigenetic, environmental and nutritional status to better predict responses of individuals.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationFollicles in a thyroid gland are highly heterogeneous in morphology and functional states, with variation in follicular size, TG content, colloid density, epithelial morphology, and iodide uptake and distribution.
“Follicles in a thyroid gland are highly heterogeneous in morphology and functional states (261, 262).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationDegon et al. constructed a complex model describing intrafollicular iodine turnover in humans, including uptake, apical transport, organification, endocytosis, recycling, secretion of iodide, upregulation of TPO, TG, NIS and other proteins by TSH, feedback inhibition of H2O2 production and NIS by iodide, and of TG, NIS, and TPO by TG.
“Degon et al. constructed a complex model describing the intrafollicular iodine turnover in humans, including uptake, apical transport, organification, endocytosis, recycling, secretion of iodide, upregulation of TPO, TG, NIS and other proteins by TSH, feedback inhibition of H2O2 production and NIS by iodide, and of TG, NIS, and TPO by TG (276).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [276] Degon, 2008, A computational model of the human thyroid, Math Biosci source
May combine two claims. The quote only partly states this claim.
InterpretationreasoningWolff-Chaikoff escape involves negative feedback regulation of multiple processes, mainly NIS downregulation, PDS upregulation, and DEHAL/DIO1 downregulation, to normalize intracellular iodide and TH synthesis and release.
“The escape phenomenon seems to be a result of adaptation in response to high intracellular iodide load, involving negative feedback regulation of multiple processes that participate in the intracellular iodide turnover ( Figure 4B , lower half).”
Quote in the paperSubstantial claim
The paper relies on this without support.
TSH stimulates the synthesis and secretion of T4 and T3 in the thyroid gland.
“In turn, TSH stimulates the synthesis and secretion of T4 and T3 in the thyroid gland.”
The paper relies on this without support.
The intrathyroidal molecular network described is sufficient to explain thyroid hormone homeostasis under physiological and pathological conditions.
“Taken together, the three different mechanisms, including the Wolff-Chaikoff inhibition effect, the Plummer effect, and the adaptive escape, work together to fend off the potentially harmful consequence of excess iodine load and ensure thyroid homeostasis.”
The paper relies on this without support.
The intrathyroidal network can be decomposed into network motifs and reassembled into an organized circuitry structure.
“by decomposing the complex molecular network in thyroid follicles into more tractable network motifs, such as feedforward and feedback, and re-assembling them into an organized circuitry structure”
The paper relies on this without support.
The nonlinear properties of feedforward and feedback regulations apply to the intrathyroidal network.
“The nonlinear properties well-known for feedforward and feedback regulations suggest that the dynamic and stimulus-response behaviors of the intrathyroidal network are not trivial”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
Cites a retracted work: 10.1210/er.2015-1098
InfoThe cited work was retracted; the date of the notice is not on record.
Cited work 10.1210/er.2015-1098 · retraction date not known · this paper published 2022-09-15
“Rapoport, 2016, TSH receptor cleavage into subunits and shedding of the a-subunit; a molecular and clinical perspective, Endocr Rev, 37, 10.1210/er.2015-1098”
Cites
1 retracted
Rapoport, B., & McLachlan, S. M. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1098 · Cited by 87 · see citing works
RetractedNetwork motifs: theory and experimental approaches
Alon, U. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2102 · Cited by 3,279 · see citing works
Structure and function of the feed-forward loop network motif
Mangan, S., & Alon, U. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2133841100 · Cited by 1,827 · see citing works
Design principles of biochemical oscillators
Novák, B., & Tyson, J. J. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2530 · Cited by 1,137 · see citing works
Ferrell, J. E. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00314-9 · Cited by 1,121 · see citing works
The Free Hormone Hypothesis: A Physiologically Based Mathematical Model*
MENDEL, C. M. (1989) · Endocrine Reviews · doi:10.1210/edrv-10-3-232 · Cited by 961 · see citing works
Thyroid hormones and cardiovascular disease
Jabbar, A., Pingitore, A., Pearce, S. H. S., Zaman, A., Iervasi, G., & Razvi, S. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.174 · Cited by 729 · see citing works
PLASMA INORGANIC IODIDE AS A HOMEOSTATIC REGULATOR OF THYROID FUNCTION
Wolff, J., & Chaikoff, I. L. (1948) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)57335-x · Cited by 596 · see citing works
The Thyrotropin (TSH)-Releasing Hormone Receptor: Interaction with TSH and Autoantibodies*
Rapoport, B., Chazenbalk, G. D., Jaume, J. C., & McLachlan, S. M. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.6.0352 · Cited by 551 · see citing works
Kimura, T., Keymeulen, A. V., GOLSTEIN, J., Fusco, A., Dumont, J. E., & Roger, P. P. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.5.0444 · Cited by 483 · see citing works
Eng, P. H. K., Cardona, G. R., Fang, S.-L., Previti, M., Alex, S., Carrasco, N., Chin, W. W., & Braverman, L. E. (1999) · Endocrinology · doi:10.1210/endo.140.8.6893 · Cited by 418 · see citing works
Royaux, I. E., Suzuki, K., Mori, A., Katoh, R., Everett, L. A., Kohn, L. D., & Green, E. D. (2000) · Endocrinology · doi:10.1210/endo.141.2.7303 · Cited by 401 · see citing works
Thyroid hormone biosynthesis and release
Carvalho, D. P., & Dupuy, C. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.01.038 · Cited by 346 · see citing works
Fekete, C., & Lechan, R. M. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1087 · Cited by 342 · see citing works
Local activation and inactivation of thyroid hormones: the deiodinase family
Köhrle, J. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00040-4 · Cited by 339 · see citing works
Deiodinases and their intricate role in thyroid hormone homeostasis
Luongo, C., Dentice, M., & Salvatore, D. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0218-2 · Cited by 332 · see citing works
The thyroxine-binding proteins
Schussler, G. C. (2000) · Thyroid · doi:10.1089/thy.2000.10.141 · Cited by 329 · see citing works
Laugwitz, K., Allgeier, A., Offermanns, S., Spicher, K., Sande, J. V., Dumont, J. E., & Schultz, G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.116 · Cited by 314 · see citing works
Zannini, M., Francis-Lang, H., Plachov, D., & Lauro, R. D. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.9.4230 · Cited by 300 · see citing works
Zannini, M., Francis-Lang, H., Plachov, D., & Lauro, R. D. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.9.4230-4241.1992 · Cited by 300
The Sodium/Iodide symporter (NIS): Molecular physiology and preclinical and clinical applications
Ravera, S., Reyna-Neyra, A., Ferrandino, G., Amzel, L. M., & Carrasco, N. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034125 · Cited by 298 · see citing works
Paradigms of dynamic control of thyroid hormone signaling
Bianco, A. C., Dumitrescu, A., Gereben, B., Ribeiro, M. O., Fonseca, T. L., Fernandes, G. W., & Bocco, B. M. L. C. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00275 · Cited by 293 · see citing works
WOLFF, J., CHAIKOFF, I. L., GOLDBERG, R. C., & MEIER, J. R. (1949) · Endocrinology · doi:10.1210/endo-45-5-504 · Cited by 292 · see citing works
Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10
Friesema, E. C. H., Jansen, J., Jachtenberg, J.-W., Visser, W. E., Kester, M. H. A., & Visser, T. J. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0112 · Cited by 285 · see citing works
Post-transcriptional regulation of the sodium/iodide symporter by thyrotropin
Riedel, C., Levy, O., & Carrasco, N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100561200 · Cited by 272 · see citing works
Zannini, M., Avantaggiato, V., Biffali, E., Arnone, M. I., Sato, K., Pischetola, M., Taylor, B. A., Phillips, S. J., Simeone, A., & Di Lauro, R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.11.3185 · Cited by 259 · see citing works
Thyroid transcription factors in development, differentiation and disease
Fernández, L. P., López-Márquez, A., & Santisteban, P. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.186 · Cited by 258 · see citing works
Ohno, M., Zannini, M., Levy, O., Carrasco, N., & Lauro, R. D. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.2051 · Cited by 255 · see citing works
Bürgi, H. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.08.010 · Cited by 249 · see citing works
Quantitative Adverse Outcome Pathways and Their Application to Predictive Toxicology
Conolly, R. B., Ankley, G. T., Cheng, W., Mayo, M. L., Miller, D. H., Perkins, E. J., Villeneuve, D. L., & Watanabe, K. H. (2017) · Environmental Science & Technology · doi:10.1021/acs.est.6b06230 · Cited by 239 · see citing works
STUDER, H., PETER, H. J., & GERBER, H. (1989) · Endocrine Reviews · doi:10.1210/edrv-10-2-125 · Cited by 235 · see citing works
“Thyroid functions of mouse cathepsins b, K and l
Friedrichs, B., Tepel, C., Reinheckel, T., Deussing, J., von Figura, K., Herzog, V., Peters, C., Saftig, P., & Brix, K. (2003) · Journal of Clinical Investigation · doi:10.1172/jci15990 · Cited by 226 · see citing works
Akamizu, T., Ikuyama, S., Saji, M., Kosugi, S., Kozak, C., McBride, O. W., & Kohn, L. D. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.15.5677 · Cited by 219 · see citing works
Russell, W., Harrison, R. F., Smith, N., Darzy, K., Shalet, S., Weetman, A. P., & Ross, R. J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2674 · Cited by 219 · see citing works
Simultaneous Measurement of Thyroxine and Triiodothyronine Peripheral Turnover Kinetics in Man
Nicoloff, J. T., LOW, J. C., Dussault, J. H., & Fisher, D. A. (1972) · Journal of Clinical Investigation · doi:10.1172/jci106835 · Cited by 217 · see citing works
The role of thyroglobulin in thyroid hormonogenesis
Citterio, C. E., Targovnik, H. M., & Arvan, P. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0184-8 · Cited by 216 · see citing works
Groeneweg, S., van Geest, F. S., Peeters, R. P., Heuer, H., & Visser, W. E. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnz008 · Cited by 216 · see citing works
Activation of Dual Oxidases Duox1 and Duox2
Rigutto, S., Hoste, C., Grasberger, H., Milenkovic, M., Communi, D., Dumont, J. E., Corvilain, B., Miot, F., & De Deken, X. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806893200 · Cited by 213 · see citing works
Silva, J. E., & Larsen, P. R. (1977) · Science · doi:10.1126/science.199941 · Cited by 198 · see citing works
Thyroid hormones and female reproduction†
Silva, J. F., Ocarino, N. M., & Serákides, R. (2018) · Biology of Reproduction · doi:10.1093/biolre/ioy115 · Cited by 198 · see citing works
G protein-coupled receptor signalling and cross-talk
Hur, E., & Kim, K. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00258-3 · Cited by 197 · see citing works
Type 2 iodothyronine deiodinase is highly expressed in human thyroid.
Salvatore, D., Tu, H., Harney, J. W., & Larsen, P. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118880 · Cited by 196 · see citing works
The classic pathways of thyroid hormone metabolism
van der Spek, A. H., Fliers, E., & Boelen, A. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.01.025 · Cited by 194 · see citing works
Abel, E. D., Ahima, R. S., Boers, M.-E., Elmquist, J. K., & Wondisford, F. E. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10858 · Cited by 192 · see citing works
The human thyrotropin receptor activates G-proteins gs and Gq/11
Allgeier, A., Offermanns, S., Van Sande, J., Spicher, K., Schultz, G., & Dumont, J. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36705-4 · Cited by 192 · see citing works
Becker, K. B., Stephens, K. C., Davey, J. C., Schneider, M. J., & Galton, V. A. (1997) · Endocrinology · doi:10.1210/endo.138.7.5272 · Cited by 185 · see citing works
Changes in thyroidal function during adaptation to large doses of iodide
Braverman, L. E., & Ingbar, S. H. (1963) · Journal of Clinical Investigation · doi:10.1172/jci104807 · Cited by 182 · see citing works
Phenolic and Tyrosyl Ring Deiodination of Iodothyronines in Rat Brain Homogenates
Kaplan, M. M., & Yaskoski, K. A. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109887 · Cited by 179 · see citing works
Dual activation by thyrotropin of the phospholipase c and cyclic AMP cascades in human thyroid
Laurent, E., Mockel, J., Van Sande, J., Graff, I., & Dumont, J. E. (1987) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(87)90055-4 · Cited by 174 · see citing works
Godbole, A., Lyga, S., Lohse, M. J., & Calebiro, D. (2017) · Nature Communications · doi:10.1038/s41467-017-00357-2 · Cited by 169 · see citing works
Munroe, D. J., & Jacobson, A. (1990) · Gene · doi:10.1016/0378-1119(90)90082-3 · Cited by 163 · see citing works
Effect of Thyroid Hormones on Neurons and Neurodevelopment
Prezioso, G., Giannini, C., & Chiarelli, F. (2018) · Hormone Research in Paediatrics · doi:10.1159/000492129 · Cited by 163 · see citing works
Gereben, B., Goncalves, C., Harney, J. W., Larsen, P. R., & Bianco, A. C. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.11.0558 · Cited by 161 · see citing works
Pendrin Is an Iodide-Specific Apical Porter Responsible for Iodide Efflux from Thyroid Cells
Yoshida, A., Taniguchi, S., Hisatome, I., Royaux, I. E., Green, E. D., Kohn, L. D., & Suzuki, K. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.7.8679 · Cited by 158 · see citing works
Coordination of hypothalamic and pituitary T3 production regulates TSH expression
Fonseca, T. L., Correa-Medina, M., Campos, M. P. O., Wittmann, G., Werneck-de-Castro, J. P., Arrojo e Drigo, R., Mora-Garzon, M., Ueta, C. B., Caicedo, A., Fekete, C., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci61231 · Cited by 155 · see citing works
Autoregulation of thyroid-specific gene transcription by thyroglobulin
Suzuki, K., Lavaroni, S., Mori, A., Ohta, M., Saito, J., Pietrarelli, M., Singer, D. S., Kimura, S., Katoh, R., Kawaoi, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8251 · Cited by 150 · see citing works
Functional Characterization of Pendrin in a Polarized Cell System
Gillam, M. P., Sidhaye, A. R., Lee, E. J., Rutishauser, J., Stephan, C. W., & Kopp, P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313648200 · Cited by 149 · see citing works
The structure of human thyroglobulin
Coscia, F., Taler-Verčič, A., Chang, V. T., Sinn, L., O’Reilly, F. J., Izoré, T., Renko, M., Berger, I., Rappsilber, J., Turk, D., et al. (2020) · Nature · doi:10.1038/s41586-020-1995-4 · Cited by 147 · see citing works
Toyoda, N., Zavacki, A. M., Maia, A. L., Harney, J. W., & Larsen, P. R. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.9.5100 · Cited by 142 · see citing works
Inherited defects of thyroxine-binding proteins
Pappa, T., Ferrara, A. M., & Refetoff, S. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.09.002 · Cited by 139 · see citing works
Di Palma, T., Nitsch, R., Mascia, A., Nitsch, L., Di Lauro, R., & Zannini, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m205977200 · Cited by 138 · see citing works
Type 1 iodothyronine deiodinase is a sensitive marker of peripheral thyroid status in the mouse
Zavacki, A. M., Ying, H., Christoffolete, M. A., Aerts, G., So, E., Harney, J. W., Cheng, S.-Y., Larsen, P. R., & Bianco, A. C. (2005) · Endocrinology · doi:10.1210/en.2004-1392 · Cited by 138 · see citing works
Thyroid Transcription Factor-1 Activates the Promoter Activity of Rat Thyroid Na+/I- Symporter Gene
Endo, T., Kaneshige, M., Nakazato, M., Ohmori, M., Harii, N., & Onaya, T. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.11.0012 · Cited by 138 · see citing works
Gnidehou, S., Caillou, B., Talbot, M., Ohayon, R., Kaniewski, J., Noël‐Hudson, M., Morand, S., Agnangji, D., Sezan, A., Courtin, F., et al. (2004) · The FASEB Journal · doi:10.1096/fj.04-2023fje · Cited by 135 · see citing works
Thyrocyte-specific Gq/G11 deficiency impairs thyroid function and prevents goiter development
Kero, J., Ahmed, K., Wettschureck, N., Tunaru, S., Wintermantel, T., Greiner, E., Schütz, G., & Offermanns, S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30380 · Cited by 124 · see citing works
DIAGNOSIS OF ENDOCRINE DISEASE: How reliable are free thyroid and total T3 hormone assays?
Welsh, K. J., & Soldin, S. J. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0193 · Cited by 124 · see citing works
Thyroid transcription factor 1 activates the promoter of the thyrotropin receptor gene
Civitareale, D., Castelli, M. P., Falasca, P., & Saiardi, A. (1993) · Molecular Endocrinology · doi:10.1210/mend.7.12.8145764 · Cited by 123 · see citing works
Peter, H. J., Gerber, H., Studer, H., & Smeds, S. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112199 · Cited by 122 · see citing works
Shimura, H., Okajima, F., Ikuyama, S., Shimura, Y., Kimura, S., Saji, M., & Kohn, L. D. (1994) · Molecular Endocrinology · doi:10.1210/mend.8.8.7997232 · Cited by 121 · see citing works
Tepel, C., Brömme, D., Herzog, V., & Brix, K. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.24.4487 · Cited by 119 · see citing works
Bartha, T., Kim, S.-W., Salvatore, D., Gereben, B., Tu, H. M., Harney, J. W., Rudas, P., & Larsen, P. R. (2000) · Endocrinology · doi:10.1210/endo.141.1.7282 · Cited by 118 · see citing works
Cell and molecular biology of transthyretin and thyroid hormones
Richardson, S. J. (2007) · International Review of Cytology · doi:10.1016/s0074-7696(07)58003-4 · Cited by 116 · see citing works
Consensus Sequences for Early Iodination and Hormonogenesis in Human Thyroglobulin
Lamas, L., Anderson, P. C., Fox, J. W., & Dunn, J. T. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)80031-x · Cited by 112 · see citing works
Stanley, M. M. (1949) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-9-10-941 · Cited by 112 · see citing works
Brix, K., Lemansky, P., & Herzog, V. (1996) · Endocrinology · doi:10.1210/endo.137.5.8612537 · Cited by 109 · see citing works
Steinsapir, J., Bianco, A. C., Buettner, C., Harney, J., & Larsen, P. R. (2000) · Endocrinology · doi:10.1210/endo.141.3.7355 · Cited by 109 · see citing works
Control of thyroid hormone secretion in normal subjects receiving iodides
Vagenakis, A. G., Downs, P., Braverman, L. E., Burger, A., & Ingbar, S. H. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107212 · Cited by 107 · see citing works
Iodine, Iodine metabolism and Iodine deficiency disorders revisited.
Ahad, F., & Ganie, S. A. (2010) · PubMed Central · Cited by 103 · see citing works
Sagar, G. D. V., Gereben, B., Callebaut, I., Mornon, J.-P., Zeöld, A., da Silva, W. S., Luongo, C., Dentice, M., Tente, S. M., Freitas, B. C. G., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00283-07 · Cited by 103 · see citing works
Thyroid Hormone Action and Energy Expenditure
Yavuz, S., Prado, S. R. S. N. D., & Celi, F. S. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2018-00423 · Cited by 103 · see citing works
Thyroglobulin processing by thyroidal proteases. Major sites of cleavage by cathepsins B, D, and L.
Dunn, A. D., CRUTCHFIELD, H. E., & Dunn, J. T. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54909-7 · Cited by 102 · see citing works
Type 2 iodothyronine deiodinase in rat pituitary tumor cells is inactivated in proteasomes
Steinsapir, J., Harney, J., & Larsen, P. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4672 · Cited by 102 · see citing works
Kleinau, G., Worth, C. L., Kreuchwig, A., Biebermann, H., Marcinkowski, P., Scheerer, P., & Krause, G. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00086 · Cited by 101 · see citing works
Regulation of the sodium iodide symporter by iodide in FRTL-5 cells
Eng, P., Cardona, G., Previti, M., Chin, W., & Braverman, L. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1440139 · Cited by 100 · see citing works
Molecular basis of PIP2-dependent regulation of the Ca2+-activated chloride channel TMEM16A
Le, S. C., Jia, Z., Chen, J., & Yang, H. (2019) · Nature Communications · doi:10.1038/s41467-019-11784-8 · Cited by 99 · see citing works
Consiglio, E., Salvatore, G., Rall, J. E., & Kohn, L. D. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50561-5 · Cited by 98 · see citing works
Antimicrobial actions of dual oxidases and lactoperoxidase
Sarr, D., Tóth, E., Gingerich, A., & Rada, B. (2018) · Journal of Microbiology · doi:10.1007/s12275-018-7545-1 · Cited by 98 · see citing works
Expression and regulation of type II iodothyronine deiodinase in human thyroid gland
Murakami, M., Araki, O., Hosoi, Y., Kamiya, Y., Morimura, T., Ogiwara, T., Mizuma, H., & Mori, M. (2001) · Endocrinology · doi:10.1210/endo.142.7.8280 · Cited by 94 · see citing works
Serrano‐Nascimento, C., Teixeira, S. D. S., Nicola, J. P., Nachbar, R. T., Masini-Repiso, A. M., & Nunes, M. T. (2014) · Endocrinology · doi:10.1210/en.2013-1665 · Cited by 94 · see citing works
Role of Megalin (gp330) in Transcytosis of Thyroglobulin by Thyroid Cells
Marinò, M., Zheng, G., Chiovato, L., Pinchera, A., Brown, D., Andrews, D. M., & McCluskey, R. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.10.7125 · Cited by 92 · see citing works
Biological feedback control-Respect the loops
El-Samad, H. (2021) · Cell Systems · doi:10.1016/j.cels.2021.05.004 · Cited by 90 · see citing works
Cysteine Proteinases Mediate Extracellular Prohormone Processing in the Thyroid
Brix, K., Linke, M., Tepel, C., & Herzog, V. (2001) · Biological Chemistry · doi:10.1515/bc.2001.087 · Cited by 89 · see citing works
Functional consequences of dual oxidase-thyroperoxidase interaction at the plasma membrane”
Fortunato, R. S., Lima de Souza, E. C., Hassani, R. A.-E., Boufraqech, M., Weyemi, U., Talbot, M., Lagente-Chevallier, O., de Carvalho, D. P., Bidart, J.-M., Schlumberger, M., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1085 · Cited by 88 · see citing works
Tissue-specific alterations in thyroid hormone homeostasis in combined Mct10 and Mct8 deficiency
Müller, J., Mayerl, S., Visser, T. J., Darras, V. M., Boelen, A., Frappart, L., Mariotta, L., Verrey, F., & Heuer, H. (2014) · Endocrinology · doi:10.1210/en.2013-1800 · Cited by 88 · see citing works
Trajkovic-Arsic, M., Müller, J., Darras, V. M., Groba, C., Lee, S., Weih, D., Bauer, K., Visser, T. J., & Heuer, H. (2010) · Endocrinology · doi:10.1210/en.2010-0593 · Cited by 87 · see citing works
Cavalieri, R. R., & SEARLE, G. L. (1966) · Journal of Clinical Investigation · doi:10.1172/jci105409 · Cited by 87 · see citing works
Kim, S.-W., Harney, J. W., & Larsen, P. R. (1998) · Endocrinology · doi:10.1210/endo.139.12.6334 · Cited by 86 · see citing works
Rapid regulation of thyroid sodium–iodide symporter activity by thyrotrophin and iodine
Ferreira, A. C. F., Lima, L. P., Araújo, R. L., Müller, G., Rocha, R. P., Rosenthal, D., & Carvalho, D. P. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.05643 · Cited by 86 · see citing works
Regulation of thyrotropin receptor gene expression in rat FRTL-5 thyroid cells
Saji, M., Akamizu, T., Sanchez, M., Obici, S., Avvedimento, E., Gottesman, M. E., & Kohn, L. D. (1992) · Endocrinology · doi:10.1210/endo.130.1.1309347 · Cited by 84 · see citing works
Morphological and functional polymorphism within clonal thyroid nodules
Aeschimann, S., Kopp, P. A., Kimura, E. T., Zbaeren, J., Tobler, A., Fey, M., & Studer, H. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.3.846 · Cited by 83 · see citing works
Morphological and functional polymorphism within clonal thyroid nodules
Aeschimann, S., Kopp, P. A., Kimura, E. T., Zbaeren, J., Tobler, A., Fey, M. F., & Studer, H. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.3.8370709 · Cited by 83
Thyroid hormone synthesis in thyroglobulin. The mechanism of the coupling reaction.
Gavaret, J. M., Cahnmann, H. J., & Nunez, J. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52523-6 · Cited by 82 · see citing works
Suzuki, K., Mori, A., Saito, J., Moriyama, E., Ullianich, L., & Kohn, L. D. (1999) · Endocrinology · doi:10.1210/en.140.11.5422 · Cited by 80 · see citing works
Hosoi, Y. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.9.3293 · Cited by 80 · see citing works
Role of thyroglobulin endocytic pathways in the control of thyroid hormone release
Marinò, M., & McCluskey, R. T. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.279.5.c1295 · Cited by 79 · see citing works
Cuesta, I., Zaret, K. S., & Santisteban, P. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00758-07 · Cited by 79 · see citing works
A Pragmatic Approach to Adverse Outcome Pathway Development and Evaluation
Svingen, T., Villeneuve, D. L., Knapen, D., Panagiotou, E. M., Draskau, M. K., Damdimopoulou, P., & O’Brien, J. M. (2021) · Toxicological Sciences · doi:10.1093/toxsci/kfab113 · Cited by 79 · see citing works
Association of duoxes with thyroid peroxidase and its regulation in thyrocytes
Song, Y., Ruf, J., Lothaire, P., Dequanter, D., Andry, G., Willemse, E., Dumont, J. E., Van Sande, J., & De Deken, X. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1727 · Cited by 77 · see citing works
Anoctamin-1/TMEM16A is the major apical iodide channel of the thyrocyte
Twyffels, L., Strickaert, A., Virreira, M., Massart, C., Van Sande, J., Wauquier, C., Beauwens, R., Dumont, J. E., Galietta, L. J., Boom, A., et al. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00126.2014 · Cited by 77 · see citing works
Intrinsic regulation of thyroid function by thyroglobulin
Sellitti, D. F., & Suzuki, K. (2014) · Thyroid® · doi:10.1089/thy.2013.0344 · Cited by 76 · see citing works
Differential Effects of Cyclic Adenosine 3',5'-Monophosphate on p70 Ribosomal S6 Kinase
Cass, L. A., & Meinkoth, J. L. (1998) · Endocrinology · doi:10.1210/endo.139.4.5880 · Cited by 76 · see citing works
Effect of excess iodine intake on thyroid on human health
Koukkou, E. G., Roupas, N. D., & Markou, K. B. (2017) · Minerva Medica · doi:10.23736/s0026-4806.17.04923-0 · Cited by 76 · see citing works
Lerman, J. (1940) · Journal of Clinical Investigation · doi:10.1172/jci101158 · Cited by 75 · see citing works
Yu, K., Jiang, T., Cui, Y., Tajkhorshid, E., & Hartzell, H. C. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1904012116 · Cited by 74 · see citing works
Ribeiro-Neto, F., Urbani, J., Lemee, N., Lou, L., & Altschuler, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082122499 · Cited by 73 · see citing works
Ortiz, L., Zannini, M., Di Lauro, R., & Santisteban, P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.37.23334 · Cited by 73 · see citing works
Sho, K., Okajima, F., Majid, M. A., & Kondo, Y. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98877-0 · Cited by 72 · see citing works
New Insights into FoxE1 Functions: Identification of Direct FoxE1 Targets in Thyroid Cells
Fernández, L. P., López‐Márquez, A., Martínez‐Montes, Á. M., Goméz-López, G., & Santisteban, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062849 · Cited by 72 · see citing works
Zhang, C.-Y., Kim, S., Harney, J. W., & Larsen, P. R. (1998) · Endocrinology · doi:10.1210/endo.139.3.5849 · Cited by 72 · see citing works
The human, but not rat, dio2 gene is stimulated by thyroid transcription factor-1 (TTF-1)
Gereben, B., Salvatore, D., Harney, J. W., Tu, H. M., & Larsen, P. R. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.1.0579 · Cited by 70 · see citing works
Studer, H., FORSTER, R., Conti, A., KOHLER, H., Haeberli, A., & Engler, H. (1978) · Endocrinology · doi:10.1210/endo-102-5-1576 · Cited by 70 · see citing works
Herzog, V., Berndorfer, U., & Saber, Y. H. A. (1992) · The Journal of Cell Biology · doi:10.1083/jcb.118.5.1071 · Cited by 70 · see citing works
Evidence of thyroid volume increase in normal subjects receiving excess iodide
Namba, H., Yamashita, S., Kimura, H., Yokoyama, N., Usa, T., Otsuru, A., Izumi, M., & Nagataki, S. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.3.8445017 · Cited by 70 · see citing works
Raben, M. S. (1949) · Endocrinology · doi:10.1210/endo-45-3-296 · Cited by 70 · see citing works
Differential regulation of apical and basal iodide transporters in the thyroid by thyroglobulin
Suzuki, K., & Kohn, L. D. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06677 · Cited by 69 · see citing works
Pax-8 protein levels regulate thyroglobulin gene expression
Fabbro, D., Pellizzari, L., Mercuri, F., Tell, G., & Damante, G. (1998) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0210347 · Cited by 69 · see citing works
Corvilain, B., SANDE, J. V., & Dumont, J. E. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(88)90279-3 · Cited by 68 · see citing works
Zaballos, M. A., Garcia, B., & Santisteban, P. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0093 · Cited by 68 · see citing works
Expression and function of the homeodomain-containing protein hex in thyroid cells
Pellizzari, L., D'Elia, A., Rustighi, A., Manfioletti, G., Tell, G., & Damante, G. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.13.2503 · Cited by 68 · see citing works
Suzuki, K., Mori, A., Saito, J., Moriyama, E., Ullianich, L., & Kohn, L. D. (1999) · Endocrinology · doi:10.1210/endo.140.11.7124 · Cited by 67
Berndorfer, U., Wilms, H., & Herzog, V. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.5.1918 · Cited by 66 · see citing works
Aza‐Blanc, P., Lauro, R. D., & Santisteban, P. (1993) · Molecular Endocrinology · doi:10.1210/mend.7.10.8264661 · Cited by 66 · see citing works
Berndorfer, U., Wilms, H., & Herzog, V (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.5.8626858 · Cited by 66
Tyrosine 130 Is an Important Outer Ring Donor for Thyroxine Formation in Thyroglobulin
DUNN, A. D., Corsi, C. M., Myers, H. E., & Dunn, J. T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.39.25223 · Cited by 65 · see citing works
LeSage, G., Marucci, L., Alvaro, D., Glaser, S. S., Benedetti, A., Marzioni, M., Patel, T. C., Francis, H., Phinizy, J. L., & Alpini, G. D. (2002) · Hepatology · doi:10.1053/jhep.2002.35537 · Cited by 65 · see citing works
Signalling pathways of insulin-like growth factor-I that are augmented by cAMP in FRTL-5 cells
Ariga, M., Nedachi, T., AKAHORI, M., SAKAMOTO, H., Ito, Y., Hakuno, F., & Takahashi, S. (2000) · Biochemical Journal · doi:10.1042/bj3480409 · Cited by 65 · see citing works
Eisenberg, M., Samuels, M., & DiStefano, J. J. (2008) · Thyroid · doi:10.1089/thy.2007.0388 · Cited by 65 · see citing works
Efficient use and recycling of the micronutrient iodide in mammals
Rokita, S. E., Adler, J. M., McTamney, P. M., & Watson Jr., J. A. (2010) · Biochimie · doi:10.1016/j.biochi.2010.02.013 · Cited by 65 · see citing works
Allen, M. D., Neumann, S., & Gershengorn, M. C. (2011) · The FASEB Journal · doi:10.1096/fj.11-188961 · Cited by 65 · see citing works
Gallo, A., Benusiglio, E., Bonapace, I. M., Feliciello, A., Cassano, S., Garbi, C., Musti, A. M., Gottesman, M. E., & Avvedimento, E. V. (1992) · Genes & Development · doi:10.1101/gad.6.9.1621 · Cited by 62 · see citing works
Ulianich, L., Suzuki, K., Mori, A., Nakazato, M., Pietrarelli, M., Goldsmith, P., Pacifico, F., Consiglio, E., Formisano, S., & Kohn, L. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.35.25099 · Cited by 62 · see citing works
Perrone, L., di Magliano, M. P., Zannini, M., & Lauro, R. D. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3232 · Cited by 60 · see citing works
Godlewska, M., & Banga, P. J. (2019) · Biochimie · doi:10.1016/j.biochi.2019.02.003 · Cited by 60 · see citing works
Iodine Suppression of Iodide Uptake in FRTL-5 Thyroid Cells
Grollman, E. F., Smolar, A. I., OMMAYA, A. E. K., Tombaccini, D., & Santisteban, P. (1986) · Endocrinology · doi:10.1210/endo-118-6-2477 · Cited by 59 · see citing works
Oguchi, H., & Kimura, S. (1998) · Endocrinology · doi:10.1210/endo.139.4.5933 · Cited by 57 · see citing works
Induction of type III deiodinase activity in astroglial cells by thyroid hormones
Esfandiari, A., Courtin, F., Lennon, A. M., Gavaret, J. M., & Pierre, M. (1992) · Endocrinology · doi:10.1210/endo.131.4.1396314 · Cited by 57 · see citing works
Ikuyama, S., Shimura, H., Hoeffler, J. P., & Kohn, L. D. (1992) · Molecular Endocrinology · doi:10.1210/mend.6.10.1333054 · Cited by 56 · see citing works
TSH regulates pendrin membrane abundance and enhances iodide efflux in thyroid cells
Pesce, L., Bizhanova, A., Caraballo, J. C., Westphal, W., Butti, M. L., Comellas, A., & Kopp, P. (2012) · Endocrinology · doi:10.1210/en.2011-1548 · Cited by 56 · see citing works
Lamas, L., & Ingbar, S. H. (1978) · Endocrinology · doi:10.1210/endo-102-1-188 · Cited by 56 · see citing works
Berberich, J., Dietrich, J. W., Hoermann, R., & Müller, M. A. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00091 · Cited by 55 · see citing works
Laurent, E., Van Sande, J., Ludgate, M., Corvilain, B., Rocmans, P., Dumont, J. E., & Mockel, J. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115178 · Cited by 55 · see citing works
Effects of thyroglobulin and pendrin on iodide flux through the thyrocyte
Kohn, L. D., Suzuki, K., Nakazato, M., Royaux, I. E., & Green, E. D. (2001) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(00)00337-4 · Cited by 54 · see citing works
Serrano‐Nascimento, C., Calil‐Silveira, J., & Nunes, M. T. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00224.2009 · Cited by 54 · see citing works
Role of cAMP, PKA and Rap1A in thyroid follicular cell survival
Saavedra, A. P., Tsygankova, O. M., Prendergast, G. V., Dworet, J. H., Cheng, G., & Meinkoth, J. L. (2002) · Oncogene · doi:10.1038/sj.onc.1205123 · Cited by 54 · see citing works
Thyroidal Iodine Heterogeneity: “Last Come, First Served” System of Iodine Turnover
Schneider, P. B. (1964) · Endocrinology · doi:10.1210/endo-74-6-973 · Cited by 53 · see citing works
Cass, L. A., & Meinkoth, J. L. (2000) · Oncogene · doi:10.1038/sj.onc.1203393 · Cited by 53 · see citing works
Hayden, L. J., Shagrin, J. M., & Young, J. A. (1970) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/bf00586371 · Cited by 52 · see citing works
Suzuki, K., MORI, A., Lavaroni, S., Miyagi, E., Ulianich, L., Katoh, R., Kawaoi, A., & Kohn, L. D. (1999) · Thyroid · doi:10.1089/thy.1999.9.319 · Cited by 52 · see citing works
Phillppou, G., Koutras, D. A., Plperlngos, G., Souvatzoglou, A., & Moulopoulos, S. D. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02267.x · Cited by 52 · see citing works
Espinoza, C., Schmitt, T., & Loos, U. (2001) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0270059 · Cited by 52 · see citing works
Congenital goitrous hypothyroidism is caused by dysfunction of the iodide transporter SLC26A7
Ishii, J., Suzuki, A., Kimura, T., Tateyama, M., Tanaka, T., Yazawa, T., Arimasu, Y., Chen, I., Aoyama, K., Kubo, Y., et al. (2019) · Communications Biology · doi:10.1038/s42003-019-0503-6 · Cited by 52 · see citing works
Genome-wide analysis of Pax8 binding provides new insights into thyroid functions
Ruiz-Llorente, S., de Pau, E. C. S., Sastre-Perona, A., Montero-Conde, C., Gómez-López, G., Fagin, J. A., Valencia, A., Pisano, D. G., & Santisteban, P. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-147 · Cited by 51 · see citing works
Roger, P., Baptist, M., & Dumont, J. E. (1992) · The Journal of Cell Biology · doi:10.1083/jcb.117.2.383 · Cited by 50 · see citing works
Review: Cysteine Proteinases Mediate Extracellular Prohormone Processing in the Thyroid
Brix, K., Linke, M., Tepel, C., & Herzog, V. (2001) · Biological Chemistry · doi:10.1515/bchm.2001.382.5.717 · Cited by 50 · see citing works
Inhibition of H2O2 production by iodoaldehydes in cultured dog thyroid cells
Panneels, V., den Bergen, H. V., Jacoby, C., Braekman, J. C., Sande, J. V., Dumont, J. E., & Boeynaems, J. M. (1994) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(94)90110-4 · Cited by 49 · see citing works
Single-Dose T3 Administration: Kinetics and Effects on Biochemical and Physiological Parameters
Jonklaas, J., Burman, K. D., Wang, H., & Latham, K. R. (2015) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000113 · Cited by 49 · see citing works
Morgan, S. J., Neumann, S., Marcus‐Samuels, B., & Gershengorn, M. C. (2016) · Thyroid · doi:10.1089/thy.2016.0323 · Cited by 49 · see citing works
Dame, K., Cincotta, S. A., Lang, A., Sanghrajka, R. M., Zhang, L., Choi, J., Kwok, L. W., Wilson, T., Kańduła, M. M., Monti, S., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.12.024 · Cited by 49 · see citing works
López-Márquez, A., Carrasco-López, C., Fernández-Méndez, C., & Santisteban, P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.654569 · Cited by 49 · see citing works
Proteolytic Processing of Thyroglobulin by Extracts of Thyroid Lysosomes*
DUNN, A. D., CRUTCHFIELD, H. E., & Dunn, J. T. (1991) · Endocrinology · doi:10.1210/endo-128-6-3073 · Cited by 48 · see citing works
Dentice, M., Luongo, C., Elefante, A., Ambrosio, R., Salzano, S., Zannini, M., Nitsch, R., Di Lauro, R., Rossi, G., Fenzi, G., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.22.10171-10182.2005 · Cited by 48 · see citing works
Inhibition of thyroid NADPH-oxidase by 2-iodohexadecanal in a cell-free system
Ohayon, R., Boeynaems, J. M., Braekman, J. C., den Bergen, H. V., Gorin, Y. C., & Virion, A. (1994) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(94)90156-2 · Cited by 47 · see citing works
Thyroid stimulating hormone upregulates secretion of cathepsin b from thyroid epithelial cells
Linke, M., Jordans, S., Mach, L., Herzog, V., & Brix, K. (2002) · Biological Chemistry · doi:10.1515/bc.2002.081 · Cited by 46 · see citing works
Regulation of Dual Oxidase Expression and H 2 O 2 Production by Thyroglobulin
Yoshihara, A., Hara, T., Kawashima, A., Akama, T., Tanigawa, K., Wu, H., Sue, M., Ishido, Y., Hiroi, N., Ishii, N., et al. (2012) · Thyroid · doi:10.1089/thy.2012.0003 · Cited by 46 · see citing works
Suzuki, K., Mori, A., Lavaroni, S., Ulianich, L., Miyagi, E., Saito, J., Nakazato, M., Pietrarelli, M., Shafran, N., Grassadonia, A., et al. (1999) · Biochimie · doi:10.1016/s0300-9084(99)80078-9 · Cited by 45 · see citing works
G13-dependent Activation of MAPK by Thyrotropin
Büch, T., Biebermann, H., Kalwa, H., Pinkenburg, O., Hager, D., Barth, H., Aktories, K., Breit, A., & Gudermann, T. W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800211200 · Cited by 44 · see citing works
Gerber, H., PETER, H. J., & Studer, H. (1987) · Endocrinology · doi:10.1210/endo-120-5-1758 · Cited by 44 · see citing works
Li, V. Q., Prentice, D. A., Howard, M. L., Mashford, M. L., & Desmond, P. V. (1999) · Pharmaceutical Research · doi:10.1023/a:1018812021549 · Cited by 43 · see citing works
Wnt-independent role of β-catenin in thyroid cell proliferation and differentiation
Sastre-Perona, A., & Santisteban, P. (2014) · Molecular Endocrinology · doi:10.1210/me.2013-1377 · Cited by 43 · see citing works
Senou, M., Khalifa, C., Thimmesch, M., Jouret, F., Devuyst, O., Col, V., Audinot, J.-N., Lipnik, P., Moreno, J. C., Van Sande, J., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0228 · Cited by 42 · see citing works
De novo triiodothyronine formation from thyrocytes activated by thyroid-stimulating hormone
Citterio, C. E., Veluswamy, B., Morgan, S. J., Galton, V. A., Banga, J. P., Atkins, S., Morishita, Y., Neumann, S., Latif, R., Gershengorn, M. C., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.784447 · Cited by 42 · see citing works
Differential gene expression analysis of iodide-treated rat thyroid follicular cell line PCCl3
Leoni, S. G., Galante, P. A., Ricarte-Filho, J. C. M., & Kimura, E. T. (2008) · Genomics · doi:10.1016/j.ygeno.2007.12.009 · Cited by 41 · see citing works
Role of thyroglobulin on negative feedback autoregulation of thyroid follicular function and growth
Suzuki, K., Kawashima, A., Yoshihara, A., Akama, T., Sue, M., Yoshida, A., & Kimura, H. J. (2011) · Journal of Endocrinology · doi:10.1530/joe-10-0486 · Cited by 41 · see citing works
Functional Morphology of the Thyroid
Fujita, H. (1988) · International review of cytology · doi:10.1016/s0074-7696(08)60848-7 · Cited by 41 · see citing works
Senou, M., Costa, M. J., Massart, C., Thimmesch, M., Khalifa, C., Poncin, S., Boucquey, M., Gérard, A.-C., Audinot, J.-N., Dessy, C., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90784.2008 · Cited by 40 · see citing works
Adler, L., Efrati, E., & Zelikovic, I. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00486.2007 · Cited by 39 · see citing works
Zoenen, M., Urizar, E., Swillens, S., Vassart, G., & Costagliola, S. (2012) · Nature Communications · doi:10.1038/ncomms1991 · Cited by 39 · see citing works
Laglia, G., Zeiger, M. A., Leipricht, A., Caturegli, P., Levine, M. A., Kohn, L. D., & Saji, M. (1996) · Endocrinology · doi:10.1210/en.137.8.3170 · Cited by 38 · see citing works
Calebiro, D., de Filippis, T., Lucchi, S., Martínez, F. O., Porazzi, P., Trivellato, R., Locati, M., Beck‐Peccoz, P., & Persani, L. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0493 · Cited by 38 · see citing works
NON-THYROGLOBULIN IODINE OF THE THYROID GLAND
Tong, W., Taurog, A., & Chaikoff, I. L. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55971-8 · Cited by 37 · see citing works
Miquelis, R., Courageot, J., Jacq, A., Blanck, O., Perrin, C., & Bastiani, P. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.123.6.1695 · Cited by 37 · see citing works
Evolution of thyroid hormone distributor proteins
McLean, T. R., Rank, M. M., Smooker, P. M., & Richardson, S. J. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.02.038 · Cited by 37 · see citing works
Thyroid-specific transcription factors
KAMBE, F., & SEO, H. (1997) · Endocrine Journal · doi:10.1507/endocrj.44.775 · Cited by 36 · see citing works
A computational model of the human thyroid
Degon, M., Chipkin, S. R., Hollot, C. V., Zoeller, R. T., & Chait, Y. (2008) · Mathematical Biosciences · doi:10.1016/j.mbs.2007.10.009 · Cited by 36 · see citing works
Ambroziak, M., Pachucki, J., Stachlewska‐Nasfeter, E., Nauman, J. A., & Nauman, A. (2005) · Thyroid · doi:10.1089/thy.2005.15.1137 · Cited by 35 · see citing works
Thyroid-specific transcription factors control hex promoter activity
Puppin, C. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg295 · Cited by 35 · see citing works
Sande, J. V., Lejeune, C., Ludgate, M. E., Munro, D. S., Vassart, G., Dumont, J. E., & Mockel, J. (1992) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(92)90024-z · Cited by 34 · see citing works
Regulation of pendrin by cAMP: possible involvement in β-adrenergic-dependent NaCl retention
Azroyan, A., Morla, L., Crambert, G., Laghmani, K., Ramakrishnan, S., Edwards, A., & Doucet, A. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00403.2011 · Cited by 34 · see citing works
Leonard, J. A., Tan, Y., Gilbert, M. E., Isaacs, K., & El-Masri, H. A. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw022 · Cited by 34 · see citing works
Flagged first, then by citations
Research works printed but not linked: 5
- Refetoff, 2000, Thyroid hormone serum transport proteins
- Peeters, 2000, Metabolism of thyroid hormone
- Masmoudi, 1997, Comparative quantification of two hepatic UDP-glucuronosyltransferase bilirubin isoforms mRNAs in various thyroid states in rat, Biochem Pharmacol, 53, 10.1016/s0006-2952(96)00886-6 · DOI
- Rousset, 2000, Thyroid hormone synthesis and secretion
- Plummer, 1923, Results of administering iodin to patients having exophthalmic goiter, J Am Med Assoc, 80
Cited by
Sorted by citations
Du, Y., Chen, C., Zhou, G., Cai, Z., Man, Q., Liu, B., & Wang, W. C. (2023) · Environmental Research · doi:10.1016/j.envres.2023.117372 · Cited by 32 · see citing works
Арыстангалиевна, Б. Г., Taskozhina, G., Арыстангалиевна, У. Г., Umarov, Y. A., Morenko, M., Iriskulov, B., Kudabayeva, K. I., & Bazargaliyev, Y. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14041274 · Cited by 20 · see citing works
Bagga, A. D., Johnson, B. P., & Zhang, Q. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1168663 · Cited by 18 · see citing works
Self-citation(EFSA), E. F. S. A., Crivellente, F., Hernández, A. F., Lanzoni, A., Metruccio, F., Mohimont, L., Nikolopoulou, D., & Castoldi, A. F. (2024) · EFSA Journal · doi:10.2903/j.efsa.2024.8672 · Cited by 17 · see citing works
Characteristics of exposure to radioactive iodine during a nuclear incident
Zaletel, K., Mihovec, A., & Gaberšček, S. (2024) · Radiology and Oncology · doi:10.2478/raon-2024-0051 · Cited by 14 · see citing works
Liu, L., Zhou, Y., Liu, J., Zhang, X., He, C., Zeng, X., Dejenie, R., Zeb, U., Zeng, Q., Liu, L., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07005-0 · Cited by 13 · see citing works
The Danish investigation on iodine intake and thyroid disease (DanThyr): history and implications
Møllehave, L. T., Knudsen, N. J., Linneberg, A. R., Pedersen, I. B., Ravn‐Haren, G., Madsen, A. L., Carlé, A., Cerqueira, C., Krejbjerg, A., Rasmussen, L. B., et al. (2024) · European Thyroid Journal · doi:10.1530/etj-23-0230 · Cited by 14 · see citing works
Xiao, L., Cheng, Y.-Q., Ma, W.-S., Zhu, W., Wu, J.-P., Meng, Y., Shi, L., Zhang, W. Y., Chen, L., Cheng, C., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.156174 · Cited by 11 · see citing works
Wang, L., Xu, H., Yang, Y., Guan, H., He, X., Wu, R., Wu, J., Yuan, N., Guo, T., Zhang, Y., et al. (2023) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2023.133094 · Cited by 10 · see citing works
Self-citationJin, Y., Zhai, T., Wang, Y., Li, J., Wang, T., & Huang, J. (2024) · Journal of Separation Science · doi:10.1002/jssc.202400466 · Cited by 9 · see citing works
Gabapentin impairs visual development in zebrafish via retinal apoptosis and thyroid disruption
He, Y., Li, X., Yang, Y., Freitas, R., Zhu, J., Ji, G., & Zhang, Y. (2025) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2025.137299 · Cited by 9 · see citing works
Thyroid hormone levels in patients with bipolar disorder: a systematic review and meta-analysis
Liu, S., Chen, X., Li, X., & Tian, L. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01776-1 · Cited by 9 · see citing works
Effects of Thyroid Hormones on Brain Development: Cytoarchitecture and Neurodevelopmental Disorders
Xin'ai, L. I., Yao, S., Ping, P., Zhou, J., & Wang, J. (2026) · The FASEB Journal · doi:10.1096/fj.202503736r · Cited by 7 · see citing works
Fisher, J. W., Housand, C., Mattie, D. R., Nong, A., Moreau, M., & Gilbert, M. E. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116733 · Cited by 7 · see citing works
Derkach, K. V., Sorokoumov, V. N., Morina, I. Y., Kuznetsova, V. S., Romanova, I. V., & Shpakov, A. O. (2024) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-024-06223-8 · Cited by 7 · see citing works
Acampora, L., Restolfer, F., Pierro, P. D., Masulli, M., Dentice, M., Sarnelli, G., & Cicatiello, A. G. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1753136 · Cited by 6 · see citing works
Schomäcker, K., Sudbrock, F., Fischer, T. H., Dietlein, F., Dietlein, M., Krapf, P., & Drzezga, A. E. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020590 · Cited by 5 · see citing works
Curcumin exerts protective effects on the thyroid gland in propylthiouracil-treated rats
Papiez, M. A. (2023) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.96497 · Cited by 5 · see citing works
Kalath, H., Koshy, A. J., Banjan, B., Soman, S., Hosadevasthana, G., Raju, R., Rehman, N., & Revikumar, A. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2270601 · Cited by 5 · see citing works
Siffo, S., Pio, M. G., Bueno‐Martínez, E., Lachlan, K. L., Walker, J. M., Weill, J., González‐Sarmiento, R., Rivolta, C. M., & Targovnik, H. M. (2022) · Endocrine · doi:10.1007/s12020-022-03284-5 · Cited by 4 · see citing works
Adam, L. N., & Abbas, A. M. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-11174-y · Cited by 3 · see citing works
Pio, M. G., Adrover, E., Miras, M. B., Sobrero, G. M., Molina, M. F., Scheps, K. G., Rivolta, C. M., & Targovnik, H. M. (2023) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2023.111948 · Cited by 3 · see citing works
Rossetti, C., Alves, B., Peçanha, F. L., Franco, A., Nosé, V., Carneiro, E. M., Lew, J. L., Bernal-Mizrachi, E., & Werneck-de-Castro, J. P. (2023) · bioRxiv · doi:10.1089/thy.2024.0053 · Cited by 3 · see citing works
Methotrexate is associated with decreased total thyroxine in patients with rheumatoid arthritis
Chen, S., Xu, Q., & Lin, C. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01299-6 · Cited by 3 · see citing works
Low-Glycemic Load Diets and Thyroid Function: A Narrative Review and Future Perspectives
Partsalaki, I., Markantes, G. Κ., & Michalaki, M. A. (2024) · Nutrients · doi:10.3390/nu16030347 · Cited by 3 · see citing works
Akane, H., Toyoda, T., Matsushita, K., Morikawa, T., Kosaka, T., Tajima, H., Aoyama, H., & Ogawa, K. (2024) · Journal of Applied Toxicology · doi:10.1002/jat.4604 · Cited by 2 · see citing works
Akane, H., Toyoda, T., Matsushita, K., Uneyama, M., Morikawa, T., Kosaka, T., Tajima, H., Aoyama, H., & Ogawa, K. (2025) · Toxicologic Pathology · doi:10.1177/01926233251316880 · Cited by 2 · see citing works
Dong, J., Liu, M., Xiang, G., Ling, Y., Xu, X., & Xiang, L. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01687-1 · Cited by 2 · see citing works
Thyroid‐Friendly Soft Materials as 3D Cell Culture Tool for Stimulating Thyroid Cell Function
Jun, I., Cho, H., Amos, S. E., Choi, Y., Choi, Y. S., Ryu, C. S., Lee, S., Han, D., Han, H., Yang, J. H., et al. (2023) · Small · doi:10.1002/smll.202300236 · Cited by 1 · see citing works
Hiron, T. K., Aguiar, J., Williams, J. M., Falcone, S., Norman, P. A., Elliott, J., Fowkes, R. C., Syme, H. M., & Davison, L. J. (2024) · Scientific Reports · doi:10.1038/s41598-024-79564-z · Cited by 1 · see citing works
Wu, R. T., Yan, L., Li, Y., Ye, T., Zhang, Y., Zhan, W., Wu, C., Lou, B., & Liang, X. (2025) · Antioxidants · doi:10.3390/antiox14111325 · Cited by 1 · see citing works
Amemiya, T., & Suzuki, H. (2026) · Endocrine · doi:10.1007/s12020-026-04758-6 · Cited by 1 · see citing works
Dual oxidase 1, 2 Gene Expression in Women With Polycystic Ovary Syndrome (PCOS)
Hesampour, A., Jafarabadi, M. N., Rajabi, S., Rezayof, E., & Ghahghaei‐Nezamabadi, A. (2023) · Journal of Family & Reproductive Health · doi:10.18502/jfrh.v17i4.14592 · Cited by 1 · see citing works
INTERPLAY BETWEEN BRAIN OXYGENATION AND THE DEVELOPMENT OF HYPOTHERMIA IN ENDOTOXIC SHOCK
Moretti, E. H., Lino, C. A., & Steiner, A. A. (2024) · Shock · doi:10.1097/shk.0000000000002350 · Cited by 1 · see citing works
Ali, E. E. E., Elkhatib, G. Z. E., & El-Ghannam, M. Z. (2024) · The Scientific Journal of Medical Scholar · doi:10.55675/sjms.v3i2.82
Abdulsada, A. A., & Neama, H. J. (2024) · Al-Rafidain Journal of Medical Sciences · doi:10.54133/ajms.v6i2.781
Qiu, R., & Fu, J. (2024) · Research Square · doi:10.21203/rs.3.rs-4840632/v1
The Impact of Nutritional and Dietary Factors on Hashimoto's Thyroiditis: A Comprehensive Review
Rybka, Z., Kamińska, M., Moczyróg, K., Karnas-Bogacka, P., Uchto, A., Dąbrowska, N., Marszałek-Moc, K., Miernik-Skrzypczak, M., Jasiewicz, M., & Palacz, K. A. (2024) · Quality in Sport · doi:10.12775/qs.2024.18.53755
Combined Molecular Toxicity Mechanism of Flame Retardant Mixtures
Li, X., & Luan, T. (2025) · doi:10.1002/9781394158355.ch15
Endocrine Glands: Their Role and Hormonal Functions in the Human Body
Khairallah, H. M., Khalf, M. G., Mujtaba Mohammed, O. D. E., Trad, A. T., & Habib, K. A. (2025) · Bright Sky Publications eBooks · doi:10.62906/bs.book.300
Hoermann, R., & Dietrich, J. W. (2025) · Springer eBooks · doi:10.1007/978-981-96-3682-2_3
Insights on thyroid function in menopause: a review
Marra, M., Zervoudis, S., Michou, V., Eskitzis, P., Iatrakis, G. M., & Mastorakos, G. P. (2025) · Review of Clinical Pharmacology and Pharmacokinetics - International Edition · doi:10.61873/mqcb4262
Liu, L.-Z., Kang, H., Li, X., Yao, H., Shi, D., & Liu, Y. (2025) · Gynecological Endocrinology · doi:10.1080/09513590.2025.2566341
Ultrastructural and morphometric features of follicular thyroid adenomas
Asanova, E., Zyablitskaya, E. Y., & Ostapenko, O. V. (2026) · Russian Journal of Archive of Pathology · doi:10.17116/patol20268801118
Teng, M., Zhuang, J., Yang, L., Chen, Y., Andersen, M. E., Zhang, Q., & Weidong, Q. (2026) · Toxicology · doi:10.1016/j.tox.2026.154428
Self-citationTargovnik, H. M., Ricci, V., Garzón, V. F., Pio, M. G., Scaglia, P. A., Masnata, M. E., Azcoiti, M. E., Izquierdo, A., Ropelato, M. G., Chiesa, A. E., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-9117442/v1
Li, J., Moyd, S. A., & Zhang, Q. (2026) · Acta Physiologica · doi:10.1111/apha.70202
Self-citationIodine-Induced Thyrotoxicosis in a Normal Thyroid Gland
Alhatemi, R., Hehar, G., Tovar, Y. E., Jun, J. Y., & Jodeh, W. (2026) · AACE Endocrinology and Diabetes · doi:10.1016/j.aed.2026.04.012
Chen, Y., Teng, M., Chen, Y., Qu, Y., Crabbe, M. J. C., Cao, Z., Andersen, M. E., Zhang, Q., Zhao, F., & Qu, W. (2026) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2026.117929
Self-citationJaniga-MacNelly, A., Barrick, A., Hoang, T. C., & Lavado, R. (2026) · Environmental Toxicology · doi:10.1002/tox.70160
Sasidharan, S. P., Yadev, I., Dileep, R. C. A., Manakkadan, A., & Ijinu, T. P. (2026) · Journal of Trace Elements and Minerals · doi:10.1016/j.jtemin.2026.100322
Tian, Z., Gao, J., Lu, Z., Chen, K., Lv, W., Ye, M., Wang, Y., Sun, Y., Yang, X., Ma, P., et al. (2026) · Food and Chemical Toxicology · doi:10.1016/j.fct.2026.116352
IODINE SUPPLEMENTATION IN CHILDHOOD: PREVENTING THYROID DISORDERS IN THE ERA OF PRECISION MEDICINE
Porwolik, A., Porwolik, H., Szydłowski, R., Cyran, P., & Bodera, M. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.2(50).2026.5466
Excess iodine intake and thyroid dysfunction
Vargas‐Uricoechea, H. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-30261-9.00026-7
Zhang, Y., Wang, X., Chang, H., Yang, H., Zhang, L., & Yang, N. (2026) · Theriogenology · doi:10.1016/j.theriogenology.2026.118209
Sleep-related disorders and thyroid gland
洪晓泉, Qiu, R., Lin, S., & Fu, J. (2026) · Medicine · doi:10.1097/md.0000000000050791
Ali, M. A., Alam-ElDein, K. M., elsayed, G. A., Ghareeb, M., hesham, R., Ali, H. A., abdelaal, R. M., mahyoub, B. A., Elshafey, M. M., Fayad, E. M., et al. (2026) · Tissue and Cell · doi:10.1016/j.tice.2026.104011
Akane, H., Takasu, S., Ishii, Y., Matsushita, K., Uneyama, M., 朋美, 森., Kosaka, T., Aoyama, H., Ogawa, K., & Toyoda, T. (2026) · Journal of Applied Toxicology · doi:10.1002/jat.70449
Tarash, Z. M., Rasheed, M. N., & Alhussin, M. (2026) · Клиническая инфектология и паразитология · doi:10.34883/pi.2026.15.2.052
- Authors
- Jing, L., & Zhang, Q.
- Affiliations
- Emory University (US)
- Corresponding author
- Zhang, Qiang
- ORCID
- Zhang, Qiang
- Venue
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Published
- 2022-09-15
- Volume
- 13
- Pages
- 992883-992883
- ISSN
- 1664-2392 (ISSN-L)
- PMC
- PMC9519864
- OpenAlex
- W4296099008
- Cited by
- 61
- References
- 282
- Citations by year
- 2026: 20 · 2025: 11 · 2024: 18 · 2023: 11 · 2022: 1
- FWCI
- 1.45
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Endocrinology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institute of Environmental Health Sciences (P42ES04911, P30ES019776)
- China Scholarship Council (201908110055)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene Regulatory Network Analysis
- Keywords
- thyroid hormone synthesis, thyroid hormone secretion, thyroid follicular cells, hypothalamic-pituitary-thyroid axis, thyroglobulin, Wolff-Chaikoff effect, transcriptional regulation, post-translational regulation, network motifs, systems biology modeling, thyroid follicles
- MeSH terms
- Feedback, Thyroglobulin, Thyroid Gland, Thyroid Hormones, Thyrotropin, Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-11-03.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-11-03.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review